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ABSTRACT OF THE DISSERTATION 
The Role of Epidermal Enhancer 923 in the Chromatin Architecture and  
Transcriptional Regulation of the Epidermal Differentiation Complex 
by 
Inez Ying Li Oh 
Doctor of Philosophy in Biology and Biomedical Sciences 
Human and Statistical Genetics 
Washington University in St. Louis, 2016 
Cristina de Guzman Strong, PhD, Chair 
 
The epidermis covers the surface of the skin and provides a functional barrier across the entire 
body. Epidermal cells or keratinocytes proliferate in the innermost basal layer and migrate 
upwards into the suprabasal spinous and granular layers as they differentiate, and finally into the 
terminally differentiated outermost stratum corneum. Keratinocytes undergoing terminal 
differentiation are marked by tissue-specific concomitant expression of genes encoded in the 
Epidermal Differentiation Complex (EDC) locus. The EDC genes are organized into four gene 
families - S100, Sprr, Lce, and Flg-like, which are coordinately expressed upon activation of the 
terminal differentiation program in keratinocytes. The molecular mechanisms that govern the 
activation of the EDC during epidermal differentiation are poorly understood.  The synteny and 
colinearity of the locus across multiple mammalian species and the coordinate expression of 
EDC genes upon keratinocyte differentiation suggest molecular mechanisms operating at the 
chromatin level. I hypothesize coordinate activation of the EDC by an enhancer regulatory 
element. Enhancers are non-coding regulatory DNA sequences that upon binding specific 
transcription factors, are able to increase expression of a proximal or distal target gene. Previous 
 
 
xi 
work in our lab identified an epidermal-specific enhancer, CNE 923, that was active in in cell-
based luciferase assays and transgenic mice.  Here, I examine the function of the 923 enhancer 
for epidermal differentiation. Using an independent transgenic mouse line, I identified 
spatiotemporal sensitivity of the 923 enhancer that correlated with the patterning of epidermal 
barrier formation during mouse embryonic development. To determine if 923 formed chromatin 
interactions with the EDC gene promoters, I performed chromosome conformation capture (3C) 
assays in proliferating and differentiated primary mouse keratinocytes. The 3C studies identified 
physiologically sensitive chromatin interactions between 923 and EDC gene promoters. The data 
supports a dynamic EDC chromatin topology during keratinocyte differentiation. A requirement 
for c-Jun/AP-1 in relation to 923-mediated EDC chromatin remodeling for normal EDC gene 
expression during keratinocyte differentiation was further determined by chromatin 
immunoprecipitation, 3C, and RNA-seq upon pharmacological inhibition of AP-1 binding. To 
further determine the function of 923 in vivo, I generated a series of mutation alleles using 
CRISPR/Cas9 genome editing in mice. Cas9 nuclease activity targeted to the flanking ends of 
the 923 enhancer in mouse zygotes by a pair of guide RNAs, coupled with homologous 
recombination-mediated loxP insertions, generated 1 floxed (923flox), 2 independent deletions 
(923delA, 923delB), and 1 partial deletion (923pdel) alleles for the 923 enhancer. My results from the 
923 knockout mice identified decreased expression of nearby Smcp, Lce6a, and involucrin gene 
expression, decreased distal Crnn and Lce gene family members, and a correlative increase in 
expression of Sprr gene family members. To identify the chromatin interactions for the 923 
enhancer on a genome-wide scale, I performed high-throughput circular chromosome 
conformation capture (4C-seq) assays with respect to the 923 enhancer and an additional Flg 
promoter viewpoint in proliferating and differentiated keratinocytes and P5424 T-cells. My 
 
 
xii 
results revealed 923 enhancer-mediated chromatin interactions indicative of a topologically 
associated domain encompassing the EDC. However, an enrichment of 923 mediated chromatin 
interactions within the EDC, were identified in keratinocytes relative to the T-cells, specifically 
between the 923 enhancer and the Sprr and Lce gene families, and with non-coding regions in 
the gene desert between the S100 and Sprr gene families. Of note was a 923 interaction with 
another putative enhancer near Crct1, enriched specifically in proliferating keratinocytes, and 
suggesting cross-talk between enhancers. Keratinocyte-specific trans-interactions identified by 
MACS and GREAT algorithms included genes important for epidermal function including 
Trp63, an important regulator of keratinocyte differentiation. Together, my 4C-seq identifies 
unique chromatin architectures of the EDC in keratinocytes and T cells, including keratinocyte-
specific enhancer-enhancer crosstalk in cis and interactions between transcriptionally active loci 
in trans. My studies identify, for the first time, a link between the 923 enhancer and proximal 
(Ivl, Smcp, Lce6a) and distal genes (Crnn, distal Lce family), the loss of which coincides with 
upregulation of other epidermal differentiation genes (Sprr family) to maintain skin barrier 
function. Together, my work has identified 923 as an epidermal-specific enhancer that 
participates in a chromatin looping network to co-regulate expression of genes important for 
epidermal development, as a mechanism for maintaining skin barrier integrity. 
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Chapter 1 
 
Introduction 
1.1 Overview 
Transcriptional regulation plays a major role in the development of the epidermis. The 
development and organization of the epidermis relies on the spatiotemporal-specific activation of 
genes in order to direct the fate of each cell. With each somatic cell containing an identical 
genome, how does the keratinocyte interpret the genome in a way that activates a transcriptional 
program specific to epidermal differentiation? Early studies of gene regulation focused on single 
gene promoters and their transcription factor binding sites (Visel et al. 2007). However, not all 
transcriptional activation is attributable to biochemical activity at the gene promoter, thus 
suggesting the contribution of other loci. The notion of a non-promoter regulatory element that 
could modulate the expression of a target gene located some distance away arose with the 
discovery of the SV40 tandem repeat sequence (Banerji et al. 1981; Benoist and Chambon 1981; 
Gruss et al. 1981; Moreau et al. 1981; Fromm and Berg 1983). The SV40 sequence “enhanced” 
transcription from distal genes in a position and independent manner, leading to coinage of the 
term, “enhancer”.  The complete genomes of humans and other model organisms in conjunction 
with Next-Generation sequencing and high-throughput methods have allowed us to identify, 
define, and ascertain the function, of regulatory elements such as enhancers on a genome-wide 
scale (Visel et al. 2007; Levo and Segal 2014; Shlyueva et al. 2014).  In this introductory 
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chapter, I discuss a history of the conceptual advances in our understanding of the enhancer in 
epidermal development, specifically with regards to EDC gene expression.  
1.2 What is an Enhancer? 
The concept of an “enhancer” emerged in 1981. In that year, Pierre Chambon and George 
Khoury independently discovered a non-coding 72 bp tandem repeat sequence upstream of the 
SV40 early gene promoters that was required for transcription (Benoist and Chambon 1981; 
Gruss et al. 1981). A subsequent study from Walter Schaffner identified the ability of the SV40 
DNA sequence to “enhance” the expression of rabbit β-globin in an expression vector even when 
the SV40 sequence was placed thousands of base pairs away from the β-globin gene promoter 
(Banerji et al. 1981). Chambon observed similar results using the gene for conalbumin (Moreau 
et al. 1981).  Further experiments performed by Paul Berg and Michael Fromm showed that the 
SV40 sequence was able to “enhance” transcription independent of its location (upstream or 
downstream of its target gene) and orientation (forward or reverse) (Fromm and Berg 1983). 
This established the SV40 sequence as the prototype of a novel genetic element, an enhancer, 
and established the definition of a classical enhancer as a non-coding sequence that can modulate 
gene expression in a position- and orientation-independent manner.  
The discovery of the SV40 enhancer paved the way for the identification of enhancers in 
other tissue types (Shlyueva et al. 2014). Often, searches for enhancers were prioritized and 
interrogated in the immediate vicinity of target genes, including upstream or downstream 
sequences (including 5’ and 3’ untranslated regions (UTRs)), introns, and intergenic regions 
(reviewed in (Kleinjan and van Heyningen 2005)).  
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In vivo studies of these putative enhancers identified the spatiotemporal specificity of 
these sequences to ensure biologically relevant cell- and tissue-specific gene expression 
(reviewed in (Levine 2010; Williamson et al. 2011)). Biochemical studies further identified 
clusters or arrays of transcription factor binding sites that act as “building blocks” of cis-
regulatory modules that also show enhancer activity (reviewed in (Hardison and Taylor 2012; 
Levo and Segal 2014; Shlyueva et al. 2014)). The enrichment of multiple transcription factor 
binding sites within an enhancer facilitates cell-specific expression largely attributable to 
combinatorial and differential binding of transcription factor family members in the context of 
different microenvironments. Based on these later studies, we more loosely define an enhancer 
as a non-coding sequence containing clusters of transcription factor binding sites that drives cell-
, tissue-, or developmental stage-specific gene expression.  
Following completion of the human genome sequence, the National Human Genome 
Research Institute, recognizing the need to more fully understand the regulation of gene 
expression, launched the Encyclopedia of Non-Coding Elements (ENCODE), a collaborative 
public research project to identify and characterize the function of noncoding elements in the 
genome, and develop the tools and technology to achieve this goal (The ENCODE Project 
Consortium 2007). Next-generation sequencing was instrumental in generating these genome 
datasets in a cost-effective manner. The ENCODE studies as well as work by others have greatly 
facilitated our ability to identify enhancers on a genome-wide scale based on chromatin 
modifications that are unique to these regulatory elements such as DNaseI hypersensitivity (open 
chromatin) and histone modification epigenetic marks (H3K27Ac, H3K4me1), and transcription 
factor binding (p300, activating TFs) associated with functional enhancers (reviewed in (Ong 
and Corces 2011; Hardison and Taylor 2012; Shlyueva et al. 2014)). The high-throughput 
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chromatin immunoprecipitation of chromatin containing specific histone modifications enabled 
the discovery of enhancers and future downstream functional analyses (reviewed in (Shlyueva et 
al. 2014)).   
1.3 Development of the Epidermis 
The epidermis is located at the surface of the skin and whose architecture provides the 
key structure for the physical barrier of the skin.  As well, the epidermis provides a tractable and 
spatially hierarchical model to investigate the development of committed cells.   Epidermal cells 
or keratinocytes within the multiple stratified layers of the epidermis must strike a critical 
balance between self-renewal and differentiation in order to build a functional epidermal barrier 
across the entire body (Hsu et al. 2014). Keratinocyte self-renewal is marked by parallel cell 
division within the basal layer.  Expression of Keratin 5 (K5) and Keratin 14 (K14) marks these 
basal proliferating keratinocytes.  
During differentiation, the basal keratinocyte asymmetrically divides giving rise to a 
basal daughter keratinocyte and a suprabasal daughter keratinocyte that migrates outwards, 
entering the spinous layer (Lechler and Fuchs 2005; Blanpain and Fuchs 2009; Hsu et al. 2014). 
Here, the spinous and granular keratinocytes activate Keratin 1 (K1) and Keratin 10 (K10) 
expression concomitant with K5/K14 downregulation. During late terminal differentiation, the 
keratinocytes coordinately express many Epidermal Differentiation Complex (EDC) genes, 
including the filaggrin (FLG) and FLG-like, late cornified envelope (LCE), small proline-rich 
region (SPRR), and S100 genes (Mischke et al. 1996; Zhao and Elder 1997; Marshall et al. 2001; 
de Guzman Strong et al. 2010). As the keratinocytes reach the outermost stratum corneum, they 
enucleate and are surrounded by their own cornified envelope (the single most basic structural 
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unit of the skin barrier) formed by the cross-linking of scaffold proteins by transglutaminase-1, 
and sealed together by keratinocyte-extruded lipids to form a semi-permeable barrier (Lechler 
and Fuchs 2005). In mice, the pattern of functional barrier acquisition corresponds to maturation 
of the cornified envelopes, and proceeds from specific dorsal initiation sites at embryonic day 
(E)16, spreading to converge at the dorsal and ventral midline so that the whole embryo is 
impermeable at E17 (Hardman et al. 1998).  
Epidermal differentiation can be recapitulated in vitro by exposing keratinocytes 
proliferating to high calcium concentrations (Yuspa et al. 1989; Pillai et al. 1990).  This process, 
called calcium switching, stimulates the calcium receptor (CaR) and downstream phosphokinase 
C (PKC) signaling, thus activating the Fos/Jun family of transcription factors that play an 
important role in keratinocyte differentiation (Reviewed in (Bikle et al. 2012)). Fos and Jun 
proteins form homo- or heterodimers that comprise the AP-1 transcription factor complex 
(Shaulian and Karin 2001). In normal epidermis as well as in organotypic epidermal cultures, the 
expression pattern of AP-1 proteins is tightly regulated even within the differentiated layers 
(Mehic et al. 2005). Fos proteins are found in the nuclei of both basal and suprabasal 
keratinocytes. JunB and JunD are expressed in all layers of normal epidermis. Interestingly, c-
Jun is expressed in the spinous layer, then disappears and reemerges in the outermost granular 
layer directly at the transition zone to the stratum corneum. Many of the genes expressed in 
keratinocytes, in either proliferative or differentiated layers of the epidermis have AP-1 binding 
sites. Together, this suggests that the binding of different combinations of AP-1 protein 
complexes to different enhancers drives the region-specific expression of the genes in the 
epidermis.  
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1.4 Epidermal Differentiation Complex 
 The EDC locus, on human chromosome 1q21 and mouse chromosome 3q, contains a 
dense cluster of genes which encode proteins that are the major molecular markers for terminal 
differentiation in the mammalian stratified epidermis.  
Loricrin and involucrin are major protein components of the cornified envelope (CE) - a 
structural unit of the skin barrier (Rice and Green 1977; Simon and Green 1984). As early 
scaffolds for the CE, loricrin and involucrin were the first EDC genes to be discovered (Eckert 
and Green 1986; Mehrel et al. 1990; Hohl et al. 1991). The functional cloning of mRNAs in UV-
treated and calcium-treated human keratinocytes led to the additional discovery of the SPRR and 
S100 genes (Kartasova and van de Putte 1988; Marenholz et al. 2004). It was later determined 
that these gene families are physically linked together on human chromosome 1q21 by the 
hybridization of gene-specific probes on electrophoresed genome restriction fragments (Volz et 
al. 1993). In 1996, the Epidermal Differentiation Complex name was proposed upon higher 
resolution mapping (Mischke et al. 1996). Later, a search for molecular markers that coincided 
spatio-temporally with skin barrier formation in mice identified a set of Expressed Sequence 
Tags (ESTs) that shared sequence homology to SPRR1 but were expressed at a later stage of 
epidermal differentiation, and therefore named late envelope proteins (LEPs) (Zhao and Elder 
1997; Marshall et al. 2001; Wang et al. 2001). The nomenclature for LEPs was subsequently 
changed to late cornified envelopes (LCEs) to more accurately reflect the shared genomic 
organization, protein homology, and expression pattern (Jackson et al. 2005). Thus, with the 
inclusion of the LCEs, the human EDC comprises a cluster of 64 coding genes and 4 gene 
families: filaggrin and FLG-like, late cornified envelope (LCEs), small proline rich region 
(SPRRs), and S100 genes (Volz et al. 1993; Rothnagel et al. 1994; Mischke et al. 1996; Song et 
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al. 1999; Jackson et al. 2005; de Guzman Strong et al. 2010). The FLG, LCE, and SPRR gene 
families encode structural components of the epidermal skin barrier, while many of the S100 
genes encode chemoattractant proteins that are expressed upon disruption of the barrier (Segre 
2006). The FLG-like genes, including trichohyalin (TCHH), repetin (RPTN), hornerin (HRNR), 
and filaggrin-2 (FLG-2), represent evolved paralogous genes given the fusion of the consensus 
S100 domain (two Ca2+-binding EF domains) to gene-specific unique central repeat and C-
terminal domains (Henry et al. 2012).  The clustering and number of the EDC genes, the shared 
homology at the N- and C-terminal domains, and the variability in the internal repeat sequences 
underscore the evolution and divergence of the EDC from a common ancestor (Backendorf and 
Hohl 1992; The Chimpanzee Sequencing and Analysis Consortium 2005).   
Loricrin-deficient mice exhibited a delay in barrier formation suggesting the existence of 
a compensatory mechanism for the skin barrier (Koch et al. 2000). Although no phenotype was 
observed in the involucrin-deficient mice (Djian et al. 2000), triple knockout mice of involucrin, 
and two non-EDC genes, periplakin and envoplakin, that contribute to the early protein scaffold 
of the cornified envelope, led to defects in the epidermal barrier (Sevilla et al. 2007).  
 The role of filaggrin in the epidermis was gleaned from human genetic studies that 
identified semi-dominant stop-gain FLG mutations in patients with ichthyosis vulgaris (IV) 
resulting in a complete loss of profilaggrin (Smith et al. 2006).  Moreover, the overlap between 
IV and atopic dermatitis (AD) led to the discovery of common loss-of-function FLG variants for 
AD in Europe (Palmer et al. 2006), and has been one of the most widely replicated genetic risk 
factors for a common disease to date (Rodríguez et al. 2009). ‘Flaky tail’ mice with dry skin, 
orthokeratosis, and acanthosis (Presland et al. 2000) also exhibited a predisposition to AD that 
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was associated with a spontaneous frameshift deletion mutation in Flg resulting in loss-of-
function and the ‘matted’ allele of Tmem79 (Fallon et al. 2009).  
 The shared biology of the EDC gene components led to the conceptual recognition of 
the EDC genes as a cluster. This in turn has been pivotal in driving current studies to understand 
the transcriptional regulation of this important locus in cutaneous biology. 
1.5 Regulation of EDC gene expression 
1.5.1 Understanding gene regulation: Pre-Human Genome Era 
Pioneer studies to elucidate gene expression for epidermal differentiation focused on the 
expressions of involucrin (IVL) and loricrin (LOR). These two important marker genes are 
distinctively expressed in terminally differentiated keratinocytes, and encode structural proteins 
that are cross-linked with many of the other proteins encoded by the EDC genes to form the 
cornified envelope (Segre 2006).  IVL is cross-linked early in the formation of the cornified 
envelope (Eckert et al. 2004) and LOR is in turn cross-linked to the existing scaffolding 
containing IVL (Nithya et al.). In the developing mouse embryo, Ivl and Lor transcripts are 
upregulated as early as E15.5 (Oh et al. 2014), and protein expression can be observed by E16.5, 
corresponding to the onset of skin barrier formation (Hardman et al. 1998; Marshall et al. 2001). 
The tight correlation of IVL and LOR expression with keratinocyte terminal differentiation 
renders these genes as ideal candidates for studying the mechanisms that underlie the switch 
from a proliferating to a differentiating program in keratinocytes. 
Involucrin 
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Transcriptional activation of involucrin (IVL) regulation using a β-galactosidase reporter 
gene construct in transgenic mice identified keratinocyte-specific expression driven by a 3.7 kb 
upstream sequence of IVL (Carroll and Taichman 1992). Using a series of deletion constructs of 
the aforementioned reporter construct, optimal expression of IVL in transgenic mice was further 
attributed to two discrete IVL upstream regions, the distal- and proximal-regulatory regions 
(DRR and PRR) (Welter et al. 1995; Banks et al. 1998). Within the DRR, an AP-1 binding site 
was required for IVL expression above basal levels, while a synergistic adjacent SP1 binding site 
was necessary for optimal expression (Banks et al. 1999). The DRR AP-1 site was found to 
interact with Fra-1, JunB, JunD, and p300, a histone acetyltransferase often associated with 
enhancers (Ogryzko et al. 1996; The ENCODE Project Consortium 2007), while the DRR SP1 
site was observed to interact with SP1, SP3, and KLF4 transcription factors (Welter et al. 1995; 
Banks et al. 1998; Balasubramanian et al. 2005; Crish and Eckert 2008; Chew et al. 2013). 
Because Fra-1 and KLF4 are known to interact with p300 (Kaczynski et al. 2003; Crish and 
Eckert 2008), this observation and others suggest a complex of transcription factors that forms 
on the DRR to drive IVL expression during keratinocyte differentiation. 
Loricrin 
Transcriptional activation of mouse loricrin expression was first localized to a 6.5 kb 
region spanning the loricrin gene (DiSepio et al. 1995). Transgenic reporter mice in which the 
LOR coding sequences were replaced by a β-galactosidase gene revealed that the remaining 1.5 
kb of 5′-flanking sequence, a small noncoding exon, a 1.1 kb intron, a single coding exon, and 
2.2 kb of 3′-flanking sequence from the mouse loricrin gene drove epidermal-specific, but not 
differentiation-specific expression. Minimal promoter activity, dependent on an AP1 site 
conserved between mouse and human, was mapped to a 60 bp upstream sequence of the 
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transcription start site. In the case of the human LOR gene, enhancers located within 1.5 kb of 5′-
flanking sequence and 9 kb of 3′-sequence were responsible for the tissue- and differentiation-
specific expression of the human LOR transgene in transgenic mice (Yoneda and Steinert 1993). 
As few as 154 bp of 5′-upstream sequence from the cap site directed expression specifically in 
cultured keratinocytes (NHEK and HaCaT), in a Sp1/c-Jun and p300/CREB-dependent manner 
(Jang and Steinert 2002). Differential occupation of the keratinocyte-specific repressor-1 (KSR-
1) comprised Sp3, CREB-1/CREMα/ATF-1, Jun B, while an AP-2-like protein was lost upon 
Sp1/c-Jun/p300/CBP recruitment during differentiation at this LOR site, thus enabling LOR 
transcriptional resolution in stratified layers (Jang and Steinert 2002). 
1.5.2 EDC loci in other mammals: Identifying Conserved Noncoding 
Elements by Comparative Genomics in the Post-Human Genome Era  
 Many of the genes in the EDC are coordinately expressed at the onset of mouse 
epidermal differentiation at embryonic (E)15.5 (de Guzman Strong et al., 2010). The dorsal-to-
ventral patterning of skin barrier formation is conserved between 4 mammalian species (mouse, 
rat, rabbit, and opossum) and is associated with concomitant EDC gene activation (Hardman et 
al., 1998; de Guzman Strong et al., 2010). These observations raised an interesting question.  
How are the EDC genes concomitantly activated? A likely explanation is the involvement of 
regulatory DNA elements such as enhancers to direct spatiotemporal expression of the EDC in 
the epidermis. The availability of complete genome sequences of the human, mouse, and other 
mammalian species greatly facilitated the timely identification of regulatory elements (Visel et 
al., 2007). Potential regulatory elements can be identified by sequence conservation in the 
noncoding regions of phylogenetically distinct animal species.  Comparative genomic sequence 
alignments of 7 orthologous mammalian EDC loci across eutherian (placental) and metatherian 
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(marsupial) highlighted the evolutionarily conserved colinearity (order of the genes) and synteny 
(located on the same chromosome) of the EDC (de Guzman Strong et al., 2010).  Moreover, 48 
conserved noncoding elements (CNEs) from the 7-mammal alignment data set were identified in 
the EDC. The regulatory activity for each CNE was tested in transfected keratinocytes using the 
firefly luciferase reporter assays. Approximately 50% of the CNEs exhibited regulatory activity, 
either enhancing or repressing luciferase activity in either or both proliferating or differentiated 
keratinocytes. The results demonstrated the physiological plasticity of these CNEs relevant to 
gene transcription.  
1.5.3 Coordinate regulation of EDC gene expression 
The discovery of enhancers in the EDC enabled hypothesis-driven research towards the 
elucidation of a potential locus control region (LCR) in the EDC.  An LCR is defined as a strong 
enhancer that is capable of directing tissue-specific expression in a position independent manner 
(Li et al., 2002).  CNE 923, located 923 kb away from the most 5’ EDC gene, was hypothesized 
to be a LCR of the EDC since it exhibited the highest reporter and hence enhancer activity in the 
keratinocytes.  The enhancer activity for 923 was further validated based on DNaseI 
hypersensitivity in primary human keratinocytes. Ectopic expression of β-galactosidase by 923 
in transgenic mice further demonstrated the epidermal-specificity of the 923 enhancer (de 
Guzman Strong et al., 2010) and recapitulated the spatio-temporal migration of epidermal barrier 
formation (Oh et al., 2014).  
While these studies supported an intriguing role for the 923 enhancer as an LCR in 
epidermal-specific transcriptional activation, the mechanism was less clear. My work, described 
in the following chapters, seeks to further elucidate the role of CNE 923 to regulate EDC 
expression. Chapter 2 details my study that further characterized the enhancer activity 923 in an 
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independent transgenic mouse line while also identifying the 923 enhancer/c-Jun/AP-1 
transcription factor axis that linked chromatin state to gene expression of the EDC (Oh et al., 
2014).  Chapter 3 discusses the function and necessity of the endogenous 923 using a mouse 
model generated via CRISPR-Cas9 genome editing (Oh et al. 2016). Finally, Chapter 4 details 
the genome-scale chromatin architectures of the EDC in keratinocytes and T cells.  
1.6 The Role of Chromatin Architecture in the Control of 
Gene Expression 
Recent cell biology studies in epidermal development have highlighted the importance of 
chromatin remodeling as a mechanism for efficient and coordinate regulation of gene clusters 
(Fessing et al. 2011; Mardaryev et al. 2013; Oh et al. 2014; Sethi et al. 2014)  During epidermal 
development, the EDC locus relocates away from the nuclear periphery and towards the nuclear 
interior prior to the activation of EDC gene expression (Gdula et al. 2013). Ablation of either 
p63, a master regulator of epidermal development (Mills et al. 1999; Yang et al. 1999; Viganò 
and Mantovani 2014), or Satb1, a higher-order genome organizer that binds to the EDC in 
epidermal progenitor cells (Fessing et al. 2011), resulted in the loss of keratinocyte-specific and 
EDC gene expression associated with alterations in the chromatin conformation of the EDC. The 
observation that p63 directly regulates the expression of Satb1, designated Satb1 as an important 
downstream target of p63 required for the proper establishment of higher-order EDC chromatin 
structure and coordinated gene expression (Fessing et al. 2011). Similarly p63 and its direct 
target Brg1 are essential in remodeling the higher-order chromatin structure of the EDC and 
positioning the locus within the 3D chromatin landscape to allow efficient expression of EDC 
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genes in epidermal progenitor cells during skin development (Mardaryev et al. 2013; Sethi et al. 
2014). 
1.6.1 The formation and biology of enhancer-promoter chromatin loops  
The idea of the formation of enhancer-promoter chromatin loops to drive gene activation 
has emerged as a major framework around which we can approach investigations of enhancer-
promoter interactions. As mentioned before, the first and thus one of the most well-studied loci, 
is the evolutionarily conserved β-globin locus important for hematopoiesis (reviewed in (Kiefer 
et al. 2008)). The 5 globin genes (ε, Gγ, Aγ, δ and β) form a cluster and are expressed in a 
developmental-stage- and tissue-specific manner controlled by a locus control region (LCR). The 
functional relevance of enhancer-promoter chromatin interactions for gene activation at this 
locus was recently demonstrated in an elegant series of studies (Deng et al. 2012). Previously, it 
was demonstrated that the GATA-1 transcription factor and Ldb1 were required to form a 
chromatin interaction between the β-globin locus control region and the β-globin promoter for 
transcriptional activation in erythroid cells (Song et al. 2007; Tripic et al. 2009). The more 
convincing experiment demonstrated a requirement for the formation of the chromatin loop for 
gene transcription arose from the use of artificial zinc fingers (ZF) (Deng et al. 2012).  
Introduction of the artificial targeted ZF forced chromatin loop formation by tethering Ldb1 to 
the β-globin locus control region in GATA-1 null erythroblasts and was sufficient to activate β-
globin gene expression. This work was the first to demonstrate the causality of chromatin spatial 
interactions in promoting gene transcription. 
My own work has also identified a role for such chromatin looping interactions in 
epidermal development.  As will be described in greater detail in Chapter 2, epidermal-specific 
enhancer 923, whose optimal activity requires AP-1 transcription factor binding, was found to 
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interact with several of the EDC gene promoters (Oh et al. 2014). The loss of AP-1 binding 
resulted in changes in 923-mediated interactions, and correlating to the loss of EDC gene 
expression during keratinocyte differentiation, demonstrating the importance of enhancer-
promoter interactions in keratinocyte differentiation. 
The identification of chromatin looping interactions 
The distant arrangement between enhancers and their target genes in metazoans incited 
debates on how the enhancers were regulating their distant target genes (Krivega and Dean 
2012). Chromatin looping and tracking were proposed as models to explain this phenomenon 
(Dean 2006). However, the first experimental confirmation of the close proximity between 
enhancers and target genes came with the chromosome conformation capture (3C) technique 
(Dekker et al. 2002). 3C was used to demonstrate that loop formation between the β-globin locus 
control region (LCR) enhancer and gene accompanied transcriptional activation (Carter et al. 
2002; Tolhuis et al. 2002; Palstra et al. 2003) and established a paradigm that was later validated 
in numerous other loci, including the α-globin gene cluster, TH2, IFNG, MHC class II and IgH 
loci (Kadauke and Blobel 2009).  Transcription factor ChIP-chip studies also revealed that 
enhancers could be located even further from their target genes than previously thought, as far as 
10-20 kbs to several Mbs away (Hong et al. 2008). Often, these proximal and distal enhancers 
interact to co-regulate a target gene.  
Recent improvements to the chromatin conformation methods have allowed us to 
examine the chromatin interactions of genomic regions at varying levels of depth and resolution. 
4C (circular chromosome conformation capture) detects all interacting sequences with a 
sequence of interest (bait such as an enhancer) (Zhao et al. 2006).  5C (chromosome 
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conformation capture carbon-copy) is designed to detect many known interactions with 
numerous baits and typically within a gene locus (Dostie et al. 2006) whereas Hi-C approach is 
aimed to detect all chromatin interactions (Lieberman-Aiden et al. 2009). Methods such as 
ChIA-PET (Chromatin interaction analysis with paired-end tag sequencing) combine the two to 
simultaneously identify genome-wide chromatin interactions and the proteins that are binding 
these interactions (Li et al. 2010).  The evidence for epigenetic modifications, chromatin looping, 
and the interplay between the two are relatively recent advancements that have provided new 
insights to our understanding of the biochemical aspects of enhancer-mediated transcriptional 
regulation. 
1.6.2 Higher-level chromatin architecture: Topologically Associated Domains 
(TAD) and Chromosome Territories (CT)  
Topologically associated domains (TADs) were first identified by Hi-C (a variation of the 
3C technique) (Dixon et al. 2012; Sexton et al. 2012).  TADs represent distinct clusters of 
enhancer-promoter interactions (Symmons et al. 2014; Lupiáñez et al. 2015). At the highest 
order of chromosome organization, spatially proximal TADs compose a chromosome territory 
(CT), which is a compartment within the nucleus that is often segregated in a chromosome-
specific manner (reviewed in (Fraser et al. 2015)). It has been noted that actively transcribed 
gene-rich loci that are in an open conformation are more likely to loop out of their CTs, 
suggesting that the space between CTs is important for genomic loci to access the transcription 
machinery (reviewed in (Fraser et al. 2015)).  
The influence of CTs over long range enhancer-promoter interactions was demonstrated 
for the developing limb bud (Amano et al. 2009). The differential expression of the Sonic 
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hedgehog (Shh) gene across regions of the limb bud as shown in the developing mouse embryo 
was mediated by specific interactions between the Shh promoter and a long-range enhancer 
MFCS1. In the intermediate portion of the limb bud which lacked ectopic Shh expression, the 
long-range enhancer was spatially and linearly distant from the Shh coding region. In the anterior 
limb bud cells, the long-range enhancer interacted with the Shh coding region, thus representing 
a poised state within their CT as Shh was not expressed. However, in the cells of the zone of 
polarizing activity (ZPA) where Shh is actively expressed, the chromatin interactions between 
the Shh promoter and MFCS1were observed in a 3D-FISH experiment to relocate outside the 
CT. Thus, the gene regulatory effect of an enhancer-promoter interaction was shown to be 
affected by the location of the interacting regions relative to their CT. 
1.6.3 Involvement of cohesin and CTCF in forming active chromatin hubs 
Enhancer activity is often modulated by a different class of regulatory elements called 
insulators that function as physical barriers to the optimal enhancer-promoter formation for 
transcriptional activation.   Here we discuss newly recognized attributes of enhancers and new 
direct roles for CCCTC-binding factor (CTCF) insulators in enhancer–promoter interactions and 
in broadly configuring the genome (Reviewed in (Krivega and Dean 2012)). 
Cohesin is a complex of proteins that holds sister chromatids together during DNA 
replication until the sister chromatids separate at anaphase (reviewed in (Hagstrom and Meyer 
2003)). The Drosophila Nipped-B gene is similar to cohesin regulatory factor Scc2 (Rollins et al. 
1999). Mutations in Nipped-B diminished the ability of an enhancer to overcome an intervening 
insulator by interacting with a distal promoter, thereby identifying what was then considered a 
non-canonical role for cohesin to regulate enhancer-promoter interactions and gene expression 
(Rollins et al. 1999). Subsequently, it was discovered that mammalian cohesin complexes can be 
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recruited to DNase I hypersensitive sites and regulatory elements by the CTCF DNA binding 
protein (Parelho et al. 2008; Rubio et al. 2008; Wendt et al. 2008). CTCF binds at insulators and 
at boundary elements to demarcate active chromatin hubs and limit the effect of enhancers 
(Wallace and Felsenfeld 2007), and cohesin contributes to CTCF’s enhancer blocking activity 
(Parelho et al. 2008; Rubio et al. 2008). Studies of the apolipoprotein gene cluster (Mishiro et al. 
2009),  the globin locus (Hou et al. 2010), and the T-cell receptor (Tcra) locus (Seitan et al. 
2011) have since demonstrated the cooperation of CTCF and cohesin to mediate insulators 
corresponding to TAD boundaries, thereby maintaining proper chromatin loop formation and 
localization of transcriptional apparatus at the gene promoters to control gene expression.  
A powerful example of the biological function of CTCF is that of chromosomal 
rearrangements of the conserved TAD-spanning WNT6/IHH/EPHA4/PAX3 locus that disrupt a 
CTCF-associated boundary domain within a TAD and cause limb malformations in humans. 
Mice harboring the equivalent disease-relevant rearrangements of the locus that interrupted a 
CTCF-associated boundary domain were generated using CRISPR/Cas9 genome editing, and 
displayed ectopic limb expression of an uninvolved gene in the locus due to misplacement of a 
cluster of limb enhancers relative to TAD boundaries (Lupiáñez et al. 2015). This demonstrated 
the functional importance of TADs for orchestrating gene expression via genome architecture 
and suggests the potential for disease-associated large-scale chromosomal abnormalities to 
pinpoint TAD boundaries. 
A more recent study identified a functional role for the directionality of a CTCF insulator 
to influence chromatin topology and enhancer-promoter function (Guo et al. 2015). Inversions of 
CTCF boundary elements in the P-cadherin enhancer using CRISPR/Cas9-genome editing 
altered the chromatin topology and gene expression.  This study demonstrated a novel governing 
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principle for chromatin architecture for gene expression by linear DNA, and holds great potential 
for the more accurate prediction of enhancers in the skin and other tissues. 
1.6.4 Super-enhancers and the role of Mediator  
 More recently, a new class of enhancers called “super-enhancers” was identified (Whyte 
et al. 2013). Super-enhancers are marked by high levels of the Mediator coactivator complex 
occupation as determined by ChIP-seq and span much larger distances than typical enhancers 
(8.7 kb versus 703 bp). Mediator is a major component of the transcription pre-initiation 
complex (PIC) machinery with RNA polymerase II (RNA pol II) and is required for activator-
dependent transcription in vitro and in vivo (reviewed in (Poss et al.)). Reduced levels of 
Mediator specifically affected gene expression near the super-enhancers (Whyte et al. 2013).  
This was convincingly demonstrated with the loss of enhancer-promoter loops of select genes 
upon loss of Mediator (Sung et al. 2005; Wang et al. 2005). Mediator-occupied super-enhancers 
also exhibited enriched binding of transcription factors that are master regulators involved in 
cell-identity including ESCs, pro-B cells, T helper cells, myotubes, and macrophages.   
The role of super-enhancers was recently identified in epidermal stem cells (Adam et al. 
2015). The target genes associated with the epidermal stem cell-specific super-enhancers 
identified by H3K27Ac and Mediator ChIP-seq methods contained a high frequency of 
transcription factor binding motifs for Sox9, Lhx2, Nfatc1 and Nfib, previously reported to be 
important for maintaining the hair follicle stem cell niche (Chang et al. 2013; Folgueras et al. 
2013; Keyes et al. 2013; Kadaja et al. 2014). As further evidence of their importance, these 
transcription factors were shown via ChIP-seq to bind at high frequency to super-enhancers 
relative to typical enhancers, in particular Sox9, corroborating its known role as a master 
transcription factor. Lineage tracing during epidermal development in the mouse, wound-healing 
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and in cell culture enabled the detection of the remodeling of super-enhancer regions and thereby 
supporting the idea that enhancers are activated or silenced in lineage-specific fashion.  The 
ability of Mediator to identify key transcription factors and enhancer sequences in a variety of 
cell types and its sensitivity to changing conditions highlights its potential as a tool to pinpoint 
important regulatory sequences involved in cell and tissue homeostasis, even without prior 
knowledge of the transcription factors or genes involved. 
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2.1 Abstract 
The Epidermal Differentiation Complex (EDC) locus comprises a syntenic and linear 
cluster of genes whose concomitant expression is a hallmark feature of differentiation in the 
developing skin epidermis. Many of the EDC proteins are cross-linked together to form the 
cornified envelope, an essential and discrete unit of the mammalian skin barrier.  The mechanism 
underlying coordinate transcriptional activation of the EDC is unknown.  Within the human 
EDC, we identified an epidermal-specific regulatory enhancer, 923, that responded to the 
developmental and spatio-temporal cues at the onset of epidermal differentiation in the mouse 
embryo.  Comparative chromosomal conformation capture (3C) assays in proliferating and 
differentiated primary mouse keratinocytes revealed multiple chromatin interactions that were 
physiologically sensitive between the 923 enhancer and EDC gene promoters and thus depict the 
dynamic, chromatin topology of the EDC.  We elucidate a mechanistic link between c-Jun/AP-1 
and 923, whereby AP-1 and 923-mediated EDC chromatin remodeling is required for functional 
EDC gene activation. Thus, we identify a critical enhancer/transcription factor axis governing the 
dynamic regulation of the EDC chromatin architecture and gene expression and provide a 
framework for future studies towards understanding gene regulation in cutaneous diseases. 
2.2 Introduction 
The epidermis lies at the surface of the skin and provides the first line of defense against 
the external environment (Koster and Roop 2007; Fuchs 2009; Kubo et al. 2012).  Protecting 
against infection and inflammation, the epidermis comprises stratified layers of epidermal cells 
or keratinocytes that are individually surrounded by a cornified envelope and function as one of 
the essential core units of the skin barrier.  To build the epidermal barrier akin to a “bricks-and-
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mortar” architecture, a basal keratinocyte in the innermost layer of the epidermis receives an 
inductive cue to differentiate and orients its mitotic spindle perpendicularly to the basement 
membrane (Lechler and Fuchs 2005).  In doing so, an asymmetric cell division gives rise to a 
basal cell and a suprabasal daughter cell that is committed to terminal differentiation.  As the 
keratinocyte completes the differentiation process, it is pushed upward and sequentially through 
the spinous and granular layers and finally to the outermost stratum corneum.  
A hallmark feature for the execution of the terminal epidermal differentiation program is 
the expression of genes encoded by the Epidermal Differentiation Complex (EDC) locus 
(Mischke et al. 1996; Zhao and Elder 1997; Marshall et al. 2001; de Guzman Strong et al. 2010).  
The EDC (located on human 1q21 and mouse 3q) consists of 4 gene families that are associated 
with skin barrier formation: Small Proline Rich Region (SPRR), Late Cornified Envelope (LCE), 
filaggrin (FLG) and filaggrin-like (FLG-like), and S100 genes.  Genes encoded in the EDC are 
coordinately activated during embryonic epidermal differentiation (de Guzman Strong et al. 
2010). Exciting and recent studies in mice have identified a role for epigenetics in the regulation 
of the EDC during skin development (reviewed in (Botchkarev et al. 2012)).  Epidermal-specific 
loss of Ezh2, an essential component of the Polycomb repressor complex for histone 
modification, resulted in early epidermal differentiation owing to precocious recruitment of AP-1 
transcription factor to the EDC for gene expression (Ezhkova et al. 2009).  Furthermore, Satb1, a 
higher-order genome organizer, was recently identified as a p63 target and binds to the EDC 
(Fessing et al. 2011).  Satb1-/- mice exhibited alterations in the chromatin conformation of the 
EDC resulting in defects in keratinocyte-specific and EDC gene expression and hence abnormal 
epidermal morphology and further demonstrated a requirement for the proper establishment of 
higher order EDC chromatin structure and coordinated gene expression.  This was further 
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supported by confocal microscopy and computational modeling that identified distinct and active 
remodeling of the nuclear architecture associated with gene expression specifically in the 
terminally differentiated keratinocyte (Gdula et al. 2013). Comprehensive studies of the β-globin 
locus control region and the X-inactivation center further support evidence for causality of 
chromatin folding and 3D genome organization with respect to gene regulation (Deng et al. 
2012; Nora et al. 2012).  However, despite these studies, the molecular mechanism(s) that 
underlie activation and coordinate regulation of the EDC genes at the nucleotide level are 
unknown.  The synteny and linearity of the EDC across a wide range of mammalian species 
suggests a molecular mechanism originating at the proximal genomic level.     
One plausible model is the activation of critical EDC expression by cis-regulatory 
elements during skin barrier formation.  Comparative genomics and the Encyclopedia of DNA 
Elements (ENCODE) consortium that has annotated 80% of the genome attributed to function 
have greatly facilitated identification of regulatory elements (Dunham et al. 2012).  We 
previously identified many conserved non-coding elements (CNEs) within the human EDC that 
could synergistically or independently coordinate EDC gene expression (de Guzman Strong et al. 
2010). Approximately 50% of them exhibit regulatory activity.  CNE 923 (approximately 923 kb 
from the transcriptional start site of S100A10, the most 5’ EDC gene) displayed the strongest 
enhancer activity in proliferating and differentiated keratinocytes in our functional screen.  This 
result corroborated with transgenic reporter mice that demonstrated epidermal-specific enhancer 
activity for CNE 923 in vivo.  This led us to hypothesize a role for 923 in the coordinate 
transcriptional activation of the EDC.   
Here, we tracked the activity of CNE 923 during development in transgenic mice and 
identified spatio-temporal sensitivity for 923 that coincides with the onset and patterning of 
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epidermal differentiation.  Chromatin conformation capture (3C) studies were employed to 
determine the physical interactions between 923 and EDC gene promoters and revealed multiple 
chromatin spatial interactions surrounding 923.  Comparative 3C analyses between proliferating 
and differentiated primary keratinocytes revealed a dynamic 923-centric EDC chromatin domain 
associated with concomitant EDC gene expression.  Comparative genomics and genetic studies 
identified an AP-1 transcription factor binding site within 923 that was required for enhancer 
activity.  We determine that the AP-1 binding site in 923 is functionally relevant, as 
pharmacological inhibition of AP-1 in calcium-induced keratinocytes repressed EDC gene 
expression and was associated with aberrant chromatin remodeling and loss of c-Jun/AP-1 
binding to 923.  Thus, our results provide a framework to examining molecular mechanisms that 
link DNA sequence to chromatin architecture and biological functions relevant to development 
and disease. 
2.3 Results 
2.3.1  923 is an epidermal-specific enhancer responsive to the spatial and 
temporal cues in the developing mouse epidermis 
We previously observed that human CNE 923 exhibited epidermal-specific enhancer 
activity, driving lacZ expression in G0 transgenic mice (923-hsp68-lacZ) analyzed only at mouse 
embryonic day (E)16.5 (de Guzman Strong et al. 2010).  However, the onset and the spatial and 
temporal patterning for 923 during mouse embryonic development were unclear.  To address 
this, we generated additional 923-hsp68-lacZ transgenic mice.  923 enhancer activity (as 
measured by lacZ transcript levels) was detected as early as E15.5 in the developing mouse 
epidermis (Figure 2.1e), and coincided with the onset of early epidermal differentiation as 
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demonstrated by positive Keratin 1 (K1) expression (Figure 2.1d) and activation of involucrin 
(Ivl), Flg, and loricrin (Lor) expression (Figure 2.1e).  X-galactose reactivity (blue) was not 
detectable at E15.5 in whole-mount or cross-sections of the epidermis (Figure 2.1a, 2.1b) owing 
to the lack of β-galactosidase protein expression.  At E16.5 and E17.5, we observed expression 
of 923 enhancer activity correlating with the patterning of barrier acquisition (dorsal to ventral 
migration pattern (Hardman et al. 1998) (Figure 2.1a).  923 β-galactosidase enhancer activity 
was localized to the spinous to stratum corneum layers of the dorsal epidermis at E16.5 and 
E17.5 (Figure 2.1b).  Failure to detect β-galactosidase activity on the dorsal epidermis of E17.5 
whole-mount embryos is consistent with barrier acquisition that precludes substrate penetration 
to detect β-galactosidase activity.  Together, the data supports the responsiveness of 923 
enhancer activity to the spatio-temporal cues of the developing mouse epidermis. 
2.3.2  The dynamic chromatin architecture of the EDC 
We previously identified DNaseI hypersensitivity for 923 (de Guzman Strong et al. 2010) 
(de Guzman Strong et al., 2010) and note ENCODE-annotated H3K4me1 histone modification 
mark in proliferating primary human keratinocytes that independently tags functional enhancers  
(Ernst et al. 2011) (Figure 2.3a).  Enhancers are known to form long-range physical interactions 
with target gene promoters for activation (Tolhuis et al. 2002).  Given these observations and the 
spatio-temporal sensitivity in the developing mouse epidermis, we hypothesized a role for 923 in 
mediating the chromatin conformation of the EDC. 
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Figure 2.1.  923 is sensitive to spatio-temporal cues during mouse embryonic epidermal 
development. (a) Whole mount lacZ staining of 923-hsp68-lacZ mice demonstrates 923 activity (β-
galactosidase/X-gal blue reactivity) following spatio-temporal patterns of epidermal barrier formation in 
the developing embryo by initial observation of activity at E16.5 (dorsal) that migrates ventrally by 
E17.5.  (b) 923 activity localizes to granular and spinous layers of embryonic dorsal epidermis with 
corresponding (c) filaggrin (FLG) and (d) keratin1 (K1) immunofluorescent staining (green). Keratin14, 
K14 (red) marks basal keratinocytes, 20X.  Dotted lines, basement membrane.  Experiments observed in 
≥ 2 independent mice. (e) 923 activity (qPCR, lacZ transcript) is noted at E15.5, E16.5, and E17.5 dorsal 
epidermis, concomitant with Flg, involucrin (Ivl), and loricrin (Lor) transcription relative to E14.5.  Error 
bars represent mean+/-SD. 
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To test this hypothesis, 3C assays coupled with quantitative PCR (qPCR) (Hagège et al. 
2007) were employed in proliferating and differentiated primary mouse keratinocytes to detect 
physical chromatin interactions at the sub-megabase level between the endogenous mouse 923 
ortholog and the EDC genes.  923 formed multiple interactions with EDC gene promoters (9 out 
of 46 tested queries, Sprr2a1, Sprr2d, Sprr2f, Sprr1b, Sprr3, Ivl, Lce1b, Lce1a2, and Crct1 
[cysteine-rich C-terminal 1]) in proliferating keratinocytes despite the lack of EDC gene 
expression relative to the differentiated keratinocytes (Figure 2.2a, 2.2b).  In differentiated 
keratinocytes, a reconfiguration of the EDC chromatin state was identified and was associated 
with eleven 923-mediated chromatin spatial interactions between a HindIII fragment 5’ of Lce3b 
and S100a6, Sprr2a1, Sprr2b, Sprr3, Sprr4, Ivl, Lce6a, Lce1b, Lce1e, and Crct1 gene promoters 
that was relatively consistent with their expression during terminal differentiation (Figure 2.2a, 
2.2b).  In comparison to the proliferating cells, the observed interactions in differentiated 
keratinocytes that were lost included Sprr2d, Sprr2f, and Sprr1b, and Lce1a2 (within 250 kb of 
923) as well as a gain with 5’ of Lce3b, S100a6, Sprr2b, Sprr4, Lce6a and Lce1e.  Notably, the 
gain of 923’s interaction with S100a6 was located 2Mb away across a gene desert and observed 
higher frequencies of interactions with Sprr2a1 and Sprr2b (both >250kb away from 923).  All 
of the above genes with the exception of Sprr2f are expressed by E15.5 as previously described 
in the newly differentiated dorsal epidermis of the developing mouse embryo (de Guzman Strong 
et al. 2010).  The genes for which there were gains of interactions in differentiated keratinocytes 
had similar if not increased levels of expression at E16.5 relative to E15.5.  These observations 
further identify a longer range EDC chromatin topology in differentiated cells (Figure 2.2a) and 
are underestimated given the modest coverage associated with 3C methodology and as not all 
keratinocytes completely differentiated.  In sum, our results support both shared and unique  
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Figure 2.2.  The Chromatin State of the Mouse EDC is Dynamic. (a) Semi-quantitative chromosomal 
conformation capture (3C-qPCR) assays were performed on primary mouse keratinocytes (proliferating 
and differentiated).  Peaks = frequencies of physical interactions observed between HindIII restriction 
fragments containing 923 (green bar) and queried restriction fragments containing/neighboring EDC gene 
promoters (black bars + gray lines) or proximal sequences (gray lines) relative to a cell-ubiquitous Ercc3 
control. HindIII fragment (5’ of Lce3b) represents a chromatin interaction that was not enhancer-promoter 
specific. Peaks, average of at least 2 biological replicates.  Error bars represent the mean+/-SEM.  (b)  
EDC gene expression heatmap (fold change) in differentiated vs. proliferating keratinocytes based on 
analysis of 3 pairwise RNA-seq libraries, green/yellow = upregulated, blue = downregulated, black = no 
change, (Table S3).  
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chromatin spatial interactions between the 923 epidermal-specific enhancer and EDC gene 
promoters in proliferating and differentiated primary mouse keratinocytes that represent the 
dynamic chromatin architecture of the EDC. 
2.3.3  AP-1 transcription factor binding is required for 923 enhancer activity 
and EDC gene expression 
To elucidate the molecular mechanism underlying 923 enhancer activity, we performed a 
bioinformatics search to identify core transcription factor binding sequences within 923 that are 
responsible for driving functional enhancer activity.  Assessment of core enhancer functional 
activity in 4 PhastCons blocks were prioritized and represent highly conserved sequences 
between 28 vertebrate species and therefore likely to impart function (Siepel et al. 2005; 
Alexander et al. 2010) (Figure 2.3b).  Deletions of blocks 1 and 4 at the 5’ and 3’ ends of 923 
significantly decreased luciferase activity (Figure 2.3c) thus demonstrating a functional role for 
these blocks for 923 enhancer activity.  As deletion of block 1 resulted in the greatest and more 
significant decrease in enhancer activity, we prioritized a search for transcription factor binding 
motifs within block 1.  We identified an AP-1 transcription factor binding site (Figure 2.4a) and 
hypothesized that AP-1 is required for 923 enhancer activity.  Deletion of the AP-1 binding site 
by site-directed mutagenesis led to a significant decrease in 923 enhancer activity under 
proliferating and differentiated conditions (Figure 2.4b) thus demonstrating a functional role for 
AP-1 to mediate 923 enhancer activity in both physiological states.    
To examine a role for AP-1 activity with respect to 923 enhancer activity and EDC gene 
activation, AP-1 binding was inhibited by Tanshinone IIA (TanIIA) treatment in primary mouse 
keratinocytes induced to differentiate (calcium induction) (Ezhkova et al. 2009).  Calcium- 
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Figure 2.3.  PhastCons (vertebrate conserved) blocks 1 and 4 are required for 923 enhancer 
activity.  (a) 923 correlates with ENCODE-annotated strong enhancer (H3K4me1) and DNaseI 
hypersensitivity clusters in normal human epidermal keratinocytes (NHEK) and 4 PhastCons blocks 
(UCSC, hg18, block 1 (23 bp): chr1:151145182-151145204; block 2 (34 bp): chr1:151145525-
151145558; block 3 (26 bp): chr1:151145572-151145597; block 4 (9 bp): chr1:151145661-151145669).  
(b) Individual deletion (del) of each PhastCons block reveals that c) blocks 1 and 4 are required for 
enhancer activity based on transient dual-luciferase reporter assays in proliferating and differentiating 
keratinocytes (n=2).  *, P = 2.05 x 10-4 , *’, 1.6 x 10-4, **, P = 31.02 x 10-3, **’, 3.51 x 10-3.  P-values are 
based on a two-tailed t-test. Error bars represent mean+/-SE. 
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Figure 2.4.  c-Jun/AP-1 transcription factor binding to PhastCons block 1 is required for 923 
enhancer activity.  (a) PhastCons block 1 contains a conserved AP-1 transcription factor binding 
sequence (UCSC, hg18, chr1:151145183-151145189).  (b) Deletion of the AP-1 binding site significantly 
decreased luciferase and hence enhancer activity (n=3), * P=1.93 x 10-4 , ** P=4.76 x 10-4 (two-tailed t-
test).  (c) Chromatin immunoprecipitation on differentiated cells demonstrates 1.6-fold decrease in AP-1 
binding to PhastCons block 1 in TanIIA-treated versus mock-treated cells (P=0.04).  The positive control, 
an ENCODE-annotated site within Keratin5 (Krt5), displayed 2.3-fold decrease in AP-1 binding in 
TanIIA-treated versus mock-treated cells (P=0.06).  A negative control (no AP-1 site) showed no 
difference between mock-treated and TanIIA-treated cells (n=2).  P-values based on a one-tailed t-test. 
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induced keratinocytes treated with TanIIA exhibited repressed EDC gene expression (Figure 
2.5b).  Moreover, chromatin immunoprecipitation for AP-1 (c-Jun) revealed that the repression 
was associated with the loss of AP-1 binding to block 1 in 923 in TanIIA-treated, calcium-
induced keratinocytes compared to mock controls (Figure 2.4c).  Together, the data demonstrates 
a requirement for AP-1 in activating EDC gene expression, specifically associated with 
functional AP-1 binding within the 923 enhancer in vivo. 
2.3.4  The c-Jun/AP-1/923 axis regulates the EDC transcriptome by 
modulating the chromatin architecture 
To identify the mechanism by which AP-1 inhibition represses EDC gene expression, we 
returned to 3C assays to examine the chromatin conformation of the EDC with respect to 923 in 
the context of AP-1 pharmacological inhibition.  The chromatin conformation was assessed at 48 
hours post-TanIIA treatment to best ascertain the direct effects of AP-1 inhibition as opposed to 
secondary effects beyond 48 hours.  Although there was no significant differences in the number 
of 923-mediated chromatin interactions in TanIIA-treated vs. mock-treated differentiated 
keratinocytes (11 vs. 12), only 6 interactions were shared (Sprr2a1, Sprr3, Ivl, Lce1d, Lce1e, and 
5’ of Lce3b) and are close by (within 325 kb) (Figure 2.5a).   Moreover, in TanIIA-treated 
keratinocytes, there was a loss of 923 interactions with Sprr2b, Sprr2d, Sprr1b, Lce6a, and 
2310050C09Rik and a gain of spatial interactions with Sprr1a, Lce1b, and Lce1c and at the 
relatively extreme 5’ and 3’ ends of the EDC reaching as far away as  >2 Mb and 866 kb in 
S100a13 and Tchh (trichohyalin), respectively.  Despite the gain of chromatin interactions, no 
appreciable differences in gene expression for Sprr1a, Lce1b, Lce1c, S100a13 and Tchh were 
observed.  It appears that AP-1 pharmacological inhibition resulting in decreased c-Jun/AP-1 
binding at 923 (Figure 2.4c) was not sufficient to completely abrogate all chromatin spatial  
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Figure 2.5.  c-Jun/AP-1 activity is required for 923-mediated chromatin state remodeling to activate 
EDC gene expression.  (a) Pharmacological inhibition of AP-1 binding using TanIIA (1.0 mg/L) 
modulates the chromatin interactions between 923 (green bar) and EDC gene promoters (gray bars) (n=2) 
in differentiated keratinocytes and (b) represses EDC gene expression based on heatmap depiction, 
yellow = upregulated, blue = downregulated in TanIIA-treated relative to mock. 
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interactions within the EDC that could be maintained by other transcription factors.  However, 
our data supports a role for AP-1 in mediating proper 923-centric EDC chromatin conformation 
for EDC gene activation. 
2.4 Discussion  
Although 3C assays and recent high-throughput genomic studies have enhanced our 
understanding of chromatin architecture and gene regulatory modules (de Wit and de Laat, 
2012), the mechanisms governing chromosomal spatial interactions are poorly understood.  Our 
studies identify a molecular mechanism describing transcription factor/enhancer modulation of a 
cluster of genes, namely AP-1 in the EDC architecture required for epidermal differentiation.  
We translate a “linear” interpretation (de Wit and de Laat 2012) of the keratinocyte genome from 
our studies and ENCODE and prioritize functional studies on 923 to elucidate the 3D structure or 
chromatin interactions within the EDC.  Our study demonstrates that 923 displays epidermal-
specific enhancer activity that tracks with spatial and temporal patterns of epidermal 
differentiation and barrier formation during normal mouse development.  We further elucidate an 
association of 923 with the coordinate activation of EDC genes during epidermal differentiation 
based on 3C assays that identified nearby chromatin spatial interactions between 923 and several 
EDC genes located as far as 2Mb away.  Specifically, we observe a chromatin state of the EDC 
in proliferating keratinocytes that are marked by fewer cis-spatial interactions with 923 and do 
not express EDC genes.  By contrast, the chromatin state of the EDC remodels in differentiated 
keratinocytes that express many EDC genes, as demonstrated by greater observed 923-mediated 
interactions with EDC gene promoters.  Although in vivo knockout studies for 923 are beyond 
the scope of this study and would address the functional role of 923 as an intriguing locus control 
region (LCR) for the EDC during mouse development, our data nevertheless support a functional 
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role for 923 in mediating the chromatin spatial interactions of the EDC.  In support of this model, 
a recent study evaluating a ZF-mediated Ldb1/β-globin LCR physical tethering to the β-globin 
promoter in GATA-1 deficient erythroid cells demonstrated causality of chromatin spatial 
interactions to gene transcription (Deng et al. 2012).  The requirement of the AP-1 binding site 
for 923 enhancer activity in both proliferating and differentiated states and the repression of EDC 
expression by pharmacological inhibition of AP-1, suggest that the AP-1/923 axis is an important 
mechanism to coordinate the EDC transcriptome.  A bioinformatic analysis of transcription 
factor binding sites in 923 suggests additional putative transcription factor binding sites 
including CREB within PhastCons Block 4 that could likely contribute to 923 enhancer function.  
It is interesting to note that even in a proliferative state, the loss of the AP-1 binding site 
in 923 led to a significant decrease in enhancer activity and chromatin interactions were observed 
between EDC gene promoters and 923.  A majority of AP-1 members are expressed in basal 
keratinocytes with a more restricted expression of specific AP-1 members in the suprabasal 
layers (Jochum et al. 2001).  AP-1 is known to translate extracellular signals to a transcriptional 
response (Schonthaler et al. 2011).  Together, these observations and our data suggest a role for 
AP-1 (c-Jun) in modulating 923 activity in basal keratinocytes by folding the EDC chromatin 
state, and for which activation of EDC transcription in the terminally differentiated keratinocyte 
is driven by the specificity of an AP-1 homo/heterodimeric partner.  Although the epidermis with 
targeted loss of c-Jun (Zenz et al. 2003) and c-Jun/JunB (Guinea-Viniegra et al. 2009) exhibited 
normal skin morphology (that could be attributed to compensatory mechanisms to correct for 
skin barrier (Koch et al. 2000; Huebner et al. 2012)), the epidermal-specific c-Jun/JunB and 
JunB knockouts exhibited inflammatory defects owing to interleukin 6 (IL-6) and tumor necrosis 
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factor α (TNFα) expression respectively.  Together, these observations lay the groundwork for 
investigations linking the role of chromatin architecture in skin barrier as well as inflammation.  
A recent study revealed that chromatin architectural proteins may play a greater role than 
transcription factors in mediating promoter-enhancer interactions (Phillips-Cremins et al. 2013).  
Genome-wide analysis of chromatin interactions lost during the differentiation of embryonic 
stem cells (ESCs) to neural progenitor cells (NPCs) unveiled a strong colocalization of the 
architectural proteins Mediator and cohesin to the ESC-specific interactions, a partial 
colocalization of the Oct4/Sox2/Nanog (OSN) transcription factors with Mediator and cohesin, 
and far fewer interactions that were enriched for only transcription factors.  The roles of 
Mediator and cohesin in mediating enhancer-promoter interactions were validated by the 
abrogation of an interaction between Olig1 and a putative ESC-specific enhancer in Mediator 
and cohesin knockdown cells.  This data suggests that a proportion of AP-1-mediated 923 
interactions may in fact be dependent on the presence of chromatin architectural proteins that are 
able to maintain these interactions even when AP-1 activity is inhibited, while a smaller 
proportion of interactions are mediated solely by AP-1.    
A genomic study has recently elucidated the chromatin topologies of the human and 
mouse genome that are marked by distinguishing structural topological domains (Dixon et al. 
2012).  These domains are stable, highly conserved, and often demarcated by boundaries 
enriched for CCCTC-binding factor (CTCF), housekeeping genes, tRNAs, and short interspersed 
nuclear element (SINE) transposons.  That the EDC is also syntenic and linear across a wide 
range of metatherian genomes (de Guzman Strong et al. 2010) suggests a model for the EDC as a 
single distinct topological domain.  Of note, ENCODE-annotated CTCF elements flank the gene 
families within and just outside the EDC, suggesting a role for CTCF as boundary elements for a 
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putative EDC topology (Ernst et al. 2011).  More high-throughput and higher resolution 
characterization of the EDC chromatin conformation using 4C or 5C methodology would 
certainly address this hypothesis as well as to depict additional chromatin interactions in an 
unbiased manner. 
The EDC has been implicated in atopic dermatitis and psoriasis (Giardina et al. 2006; 
Palmer et al. 2006; Sandilands et al. 2007; de Cid et al. 2009; Esparza-Gordillo et al. 2009; 
Hirota et al. 2012; Paternoster et al. 2012).  Specifically, discovery of FLG mutations initially in 
ichthyosis vulgaris (Smith et al. 2006) and particularly in atopic dermatitis (AD) (Palmer et al. 
2006) and other atopic diseases such as asthma and allergic rhinitis (Irvine et al. 2011), 
highlights the importance of how even one of the EDC components broadly affects prevalent 
allergic diseases.  Even at the exclusion of common FLG mutations, genetic association to the 
EDC continues to persist in atopic dermatitis suggesting additional genetic variants within the 
EDC (Morar et al. 2007; Esparza-Gordillo et al. 2009).  Our analysis provides a genomic 
framework for which we can begin to interrogate regulatory element variants as causative in 
these diseases. Although discovery of causative variants is prioritized in genomic regions in 
linkage disequilibrium (LD) with genome-wide association study (GWAS)-identified SNPs, our 
chromatin experiments suggest discovery of causative SNPs that are not in LD but are in 
“physical proximity” and trans to GWAS-identified SNPs. 
2.5 Materials and Methods 
2.5.1  Mice 
h923-hsp68-lacZ reporter FVB/N mice were housed in pathogen-free, barrier facilities at 
NIH (Bethesda, MD) and Washington University School of Medicine (St. Louis, MO).  All 
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animal procedures were approved by the NHGRI Animal Care and Use Committee and 
Washington University Division of Comparative Medicine Animal Studies Committee.  All 
animal work was conducted in accordance with the Guide for the Care and Use of Laboratory 
Animals of the National Institutes of Health.  Morning observation of a vaginal plug was 
designated as embryonic day (E) 0.5. 
2.5.2  LacZ staining and Immunohistochemistry 
Whole-mount embryos and frozen OCT sections were stained overnight for β-
galactosidase activity as previously described (de Guzman Strong et al. 2010) and imaged on a 
Nikon SMZ 1500 Stereomicroscope and a Nikon Eclipse 80i brightfield microscope (Nikon, 
Tokyo, Japan), respectively.  Primary antibodies used for immunofluorescence are rabbit K1 
(17iKSCN, 1:500), rabbit FLG (5C-KSCN, 1:500) and chicken K14 (5560, 1:1000) (courtesy of 
J. Segre).  Secondary antibodies used were goat anti-rabbit (Alexa Fluor 488, 1:500) and goat 
anti-chicken (Alexa Fluor 594, 1:1000) IgG antibodies (Life Technologies, Frederick, MD).  
Sections were fixed in 4% paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA) prior 
to permeabilization with 0.1% Triton X-100 and subsequent antibody incubation.  Sections were 
counterstained with SlowFade Gold antifade reagent with DAPI (Life Technologies, Frederick, 
MD) prior to fluorescent imaging on a Zeiss AxioImager Z1 and captured with AxioCam MRc 
and Axiovision software (Carl Zeiss, Stockholm, Sweden).  
2.5.3  Chromosomal conformation capture (3C) assay 
Primary keratinocytes were isolated from newborn mice as previously described (Lichti 
et al., 2008) and plated under proliferating or differentiating (2.0 mM Ca2+) conditions in custom 
keratinocyte media.  3C assays were performed as previously described (Hagège et al. 2007).  
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Briefly, approximately 10 million cells were harvested at 72 hours post-calcium treatment and 
cross-linked with 2% formaldehyde prior to overnight HindIII (New England Biolabs, Ipswich, 
MA) digestion.  Each 3C library was assessed for efficient digestion efficiency by qPCR, and 
then further ligated with T4 DNA ligase (New England BioLabs, Ipswich, MA) overnight, 
decrosslinked using Proteinase K (IBI Scientific, Peosta, IA), and purified by phenol/chloroform 
(Life Technologies, Frederick, MD).  Each putative physical interaction between 923 and an 
EDC gene promoter (detected by head-to-head [same strand] primer pair within 50-150 bp of a 
HindIII cut site and designed in NCBI37/mm9, Table S1) was detected by qPCR (Quantitect 
SYBR Green, Qiagen, Chatsworth, CA, ViiA7, Applied Biosystems, Foster City, CA) in 
triplicate in 3C libraries of equivalent concentrations. CT values for each measured interaction 
were normalized against CT values across an uncut region and a pan-cell Ercc3 chromatin 
interaction (Hagège et al. 2007).  Positive 3C interactions represent a minimum average of at 
least 1 replicate from 2 independent 3C libraries as a criterion to best exclude false positive and 
random events.  
2.5.4  RNA isolation and analysis 
RNA-seq  RNA isolation and analysis is described in supplementary methods (Appendix A). 
RNA-seq data have been deposited in the NCBI SRA under accession number PRJNA210793. 
qRT-PCR  Real-time qPCR on cDNA (generated using SuperScript II reverse transcriptase (Life 
Technologies)) using SYBR Green was performed in triplicate (ABI ViiA7, Foster City, CA) 
and normalized to β2-microglobulin.  Only CT values with single peaks on melt-curve analyses 
were included.  Primers are listed in Table S2.  
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2.5.5  Luciferase assay 
923 deletion constructs were cloned synthetically (IDT) or by PCR amplification.  AP-1 
site deletion was generated by site-directed mutagenesis (QuikChange Site-Directed Mutagenesis 
Kit, Agilent, Palo Alto, CA).  All clones were verified by Sanger sequencing.  Dual luciferase 
assays were performed in duplicate as previously described (de Guzman Strong et al. 2010).  
2.5.6  Transcription factor binding prediction 
Transcription factor binding sites were predicted by aligning each PhastCons block 
sequence (with a relative profile score threshold of 80%) against the JASPAR CORE database of 
transcription factor binding profiles (http://jaspar.genereg.net/) (Bryne et al. 2008).  
2.5.7  AP-1 binding inhibition assay 
Primary keratinocytes grown under differentiating conditions (2.0mM Ca2+) were treated 
with either 1.0mg/L Tanshinone IIA (Biomol, Plymouth Meeting, PA) or DMSO (mock) during 
calcium shifting 24 hours after plating.  Cells were harvested at 2 days post-calcium treatment 
for 3C assays and RNA isolation for gene expression analysis by real-time qPCR.  
2.5.8  Chromatin Immunoprecipitation 
Chromatin (approximately 5 x 106 cells) was sonicated (Bioruptor XL [Diagenode, 
Denville, NJ]) prior to immunoprecipitation with rabbit antibodies: c-Jun (AP-1) (Abcam, 
Cambridge, MA; Cat. # ab31419) and IgG (Millipore, Billerica, MA; Cat. # 12-370) antibodies 
bound to Dynabeads Protein A (Life Technologies).  ChIP Primers are listed in Table S4. 
2.6 Supplementary Material 
Supplementary material may be viewed in Appendix A. 
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3.1 Abstract 
Tissue-specific gene expression is driven largely by enhancers.  Despite genome-wide discovery 
of enhancers in the skin, their function in skin biology is not fully known.  Here we address the 
function of the epidermal-specific enhancer 923 in the Epidermal Differentiation Complex 
(EDC) locus via CRISPR/Cas9 genome editing in mice.  Targeting of the 923 enhancer in mouse 
zygotes using a pair of flanking guide RNAs to direct Cas9 nuclease activity coupled with 
homologous recombination-mediated loxP insertions generated 1 floxed (923flox), 2 independent 
deletions (923delA, 923delB), and 1 partial deletion (923pdel) 923 enhancer alleles. Our results 
identify a significant dose-dependent requirement of the 923 enhancer for nearby Ivl, Smcp, and 
Lce6a gene expression, distal Lce3 and Crnn gene expression, and a compensatory increase in 
members of the Sprr gene family (Sprr4, Sprr2i, Sprr2g, etc.) to reinforce the epidermal barrier. 
The results demonstrate a requirement of the 923 enhancer for directing proximal and distal gene 
expression. 
3.2 Introduction 
Enhancers are regulatory elements that drive tissue-specific gene expression and are often 
critical for cell fate decision and function. Despite genome-wide discovery of enhancers across a 
wide and diverse range of tissues and cell types using ChIP-seq studies, we know very little 
about how the enhancer regulates gene expression in vivo. The concomitant activation of the 
genes encoded by the Epidermal Differentiation Complex (EDC) specific to the stratified skin 
epidermis and the discovery of enhancers within the EDC provides a unique opportunity to 
investigate enhancer-driven events in EDC activation specific to the skin. We initially identified 
several candidate enhancers within the EDC locus based on sequence conservation across a wide 
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range of mammalian species (de Guzman Strong et al. 2010). Their enhancer activities were 
confirmed in cell-based reporter assays and were dynamic and physiologically dependent. The 
923 enhancer in the human EDC, named after its kb distance away from the most 5’EDC gene, 
S100A10, demonstrated the highest activity in this assay as well as being DNaseI hypersensitive.  
Moreover, 923 exhibited epidermal-specific activity and was sensitive to the spatiotemporal cues 
during epidermal development (de Guzman Strong et al. 2010; Oh et al. 2014). Chromosome 
conformation capture studies further revealed remodeling of the mouse EDC surrounding the 
endogenous 923 enhancer upon epidermal differentiation and a requirement for the AP-1 
transcription factor binding to 923 for inducing EDC expression.  Given these results, we 
hypothesized that the 923 enhancer is required for EDC gene activation and the development of 
the epidermis. To test this hypothesis, we generated mice with a deletion of the 923 enhancer 
using the CRISPR/Cas9 genome editing tool. Loss of the 923 enhancer in two independent 
mouse models for the 923 deletion exhibited a dose-dependent decrease in proximal gene 
expression of Ivl, Smcp, and Lce6a, distal gene expression of Lce3e, Lce3f, and Crnn, and an 
observed compensatory increase in the Sprr family members to reinforce the epidermal barrier. 
Together, our data identifies a requirement for the 923 enhancer for proximal and distal gene 
expression in the EDC.  
3.3 Results 
3.3.1  Generation of an Allelic Series of the EDC 923 enhancer in mice using 
CRISPR/Cas9 Genome Editing 
To generate a deletion for the 923 enhancer, we employed the CRISPR/Cas9 genome 
editing strategy in mice. Two short guide (sg)RNA were designed to target the flanking ends of 
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the orthologous mouse 923 sequence for cleavage by Cas9. Two single stranded 
oligodeoxynucleotides (ssODNs), each containing a loxP site and a restriction enzyme 
recognition site flanked by specific homology arms, were also introduced to generate a floxed 
allele. The strategy leverages endogenous DNA repair mechanisms in response to Cas9-induced 
double strand breaks, generating a floxed allele by homology-directed repair enabled by the 
ssODNs, as well as a deletion allele by non-homologous end joining (Figure 3.1a). Targeting 
specificity was verified using in vitro pilot studies prior to zygote injection. Of the 779 
C57BL6/6XCBA hybrid zygotes injected, 80 F0 newborns were recovered, of which 75 survived 
to weaning age.  Our initial PCR screen identified 7 out of 80 mice whose 923 allele size 
deviated from the wild type allele (partial or full deletions) demonstrating 8.75% targeting 
efficiency.  We also identified loxP insertion at either the 5’ or 3’ end at 13.75% efficiency 
collectively (5’ only: 3/80; 3’ only: 5/80; 5’ and 3’: 3/80). From these mice, we confirmed 
germline transmission for one floxed allele (923flox) with both loxP inserting in cis, two deletion 
alleles (923delA, 923delB), and one partial deletion with 238 bp of 923 intact (923pdel) (Figure 
3.1b).  Additionally, the 923delA allele of 923 was flanked by both 5’ and 3’ loxP sites, while the 
923delB allele also contained a 3’ loxP site. 
3.3.2  923 deletion mice were viable and appeared normal 
To directly identify the phenotype for the loss of the 923 enhancer, we first prioritized 
our studies on the homozygous 923delA, 923delB, and 923pdel -/- mice. All 923delA, 923delB, and 
923pdel -/- mice appeared normal throughout gestation and into adulthood and were viable (Figure 
3.2, 3.5).  This was further supported by no deviations of expected versus observed genotypes for  
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Figure 3.1. CRISPR/Cas9 targeting strategy. a) 2 sgRNAs were used to target Cas9 nuclease to 
specific sites flanking 923. 2 ssODNs were introduced to insert loxP sequences into the cleavage sites by 
homology-directed repair. b) Generation of multiple 923 enhancer alleles by CRISPR/Cas9 genome 
editing.  
53-5 (923fl/fl): Successfully introduced loxP sites flanking (positions) 923 in the mouse genome to create a 
floxed conditional deletion. Same strand 5’ and 3’ loxP sites confirmed by generation of F2s and cloning 
and sequencing. 
923delA: Global deletion of whole 923 sequence. Insertion of flanking loxP sites. 
923delB: Global deletion of whole 923 sequence. Larger region deleted in 59-10. 
923pdel: Global deletion of partial 923 sequence.  Loss of blocks 2, 3, and 4. Block 1 intact. 
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Figure 3.2. 923 deletion mice are viable and appear normal. Homozygous deletion mice do not appear 
different under normal housing conditions, when compared to heterozygous and homozygous wildtype 
littermates. 
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all 3 heterozygous parental crosses even after several generations of backcrossing to control for 
possible off-target effects (Χ2 test, α=0.05) (Table S1). Normal fecundity was also observed for 
both 923delA and 923delB -/- mice (data not shown). Thus, the data demonstrate that the loss of the 
923 enhancer does not affect overall viability under the conditions in which the mice were 
housed. 
3.3.3  Skin barrier appears normal in 923 deletion mice 
We next investigated the function of the skin barrier in the 923delA and 923delB -/- mice. 
No gross morphological differences in the skins of 923delA and 923delB +/- and -/- mice (both 
newborn and 8-week) compared to the respective wildtype littermates were observed (Figure 
3.3).  
We subsequently examined the morphology of the cornified envelopes from 923delA, 
923delB, and 923pdel -/- mice that contribute to the structural integrity of the skin barrier. Equal 
quantities of angular and balloon shaped cornified envelopes from newborn 923delA, 923delB, and 
923pdel -/- mice were observed compared to their wild type littermates (Figure 3.4). Similarly, the 
edges of the cornified envelopes appeared smooth for all 923 homozygous knockout mice, 
indicating no observable structural differences of the cornified envelopes as well.  
As both 923delA and 923delB -/- mice appeared normal, we sought to determine if the 
development of skin barrier formation in the mouse embryo was delayed due to the loss of 923.  
Delayed skin barrier formation has been observed in several mouse models that revealed a 
compensatory mechanism to correct the skin barrier during development (Koch et al. 2000; 
Strong et al. 2006). No apparent differences in the patterning and temporal development of skin 
barrier formation were observed in the homozygous 923delA and 923delB -/- embryos compared to  
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Figure 3.3. Normal histology of 923 deletion mouse epidermis. 923 deletion mice appear to have 
normal epidermal structure based on H&E staining of epidermal sections from a) newborn mice, and b) 8 
week old mice. 
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Figure 3.4. Normal cornified envelope morphology in 923 deletion and partial deletion mice. Similar 
quantities of angular and balloon shaped cornified envelopes with smooth edges were isolated from 
newborn skin of homozygous deletion, heterozygous and wildtype littermates of 923delA, 923delB, and 
923pdel lines. 
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wild type and heterozygous littermates assessed by blue X-gal reactivity as a proxy for outside-in 
barrier formation (Fig. 3.5). Together, our results indicate normal skin barrier function with 
respect to skin morphology, cornified envelope formation, and skin barrier development with the 
loss of the 923 enhancer in mice.  
3.3.4  The 923 enhancer is required for dose-dependent expression of proximal 
gene Ivl, Smcp, Lce6a, and distal Crnn and Lce3 genes 
 To determine the effect of the loss of the 923 enhancer on the skin transcriptome, we 
performed RNA-seq on newborn skin.  We treated the independent deletion lines, 923delA and 
923delB, as biological replicates to account for stochastic changes in gene expression not due to 
the loss of 923. Our results identified a significant decrease (adjusted p-value <0.05) in the 
expression of the proximal gene Ivl, and the distal gene Crnn in 923del -/- mice in comparison to 
heterozygous and wildtype newborn littermates (Figure 3.6a). Additionally, while statistical 
significance was not achieved, a decrease was noted in the expression of proximal genes Smcp 
and Lce6a, and distal genes Lce3a, Lce3b, Lce3e and Lce3f. Moreover, we determined that the 
decrease in Ivl, Smcp and Crnn expression was dose-dependent with 923del +/- mice exhibiting 
approximately 50% less Ivl and Crnn expression compared to wild-type littermates. The 
magnitude of the difference in expression was greatest for Ivl, which displayed a 30-fold 
decrease in 923del -/- relative to wild-type littermates. The dose-dependent decrease in Ivl was 
also observed by qPCR in cultured primary keratinocytes isolated from 923delB -/- newborn mice 
in comparison to wild-type and heterozygous littermates, confirming a cell-intrinsic effect  
(Figure 3.6d). The observed decrease in Ivl gene expression appeared to thus lead to reduced 
involucrin protein expression in the epidermis (Figure 3.6a, c). By contrast, 923pdel-/- newborn  
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Figure 3.5. Normal patterning of skin barrier development in 923 deletion mice. The extent of skin 
barrier formation was assessed by an outside-in X-gal dye penetration assay. Blue stain indicates X-gal 
reactivity with endogenous β-galactosidase where the X-gal solution has penetrated the epidermis where 
the skin barrier has not formed.  
  
923delA 
E15.5 
E16 
E17.5 
923delB 
+/+ +/- -/- +/+ +/- -/- 
 
 
63 
 
Figure 3.6. Deletion of 923 results in loss of proximal and distal gene expression. a) RNA-seq to 
assess gene expression in the skin of newborn mice revealed a dose-dependent decrease in neighbouring 
genes, Ivl, and Smcp, and Lce6a, and a compensatory increase in the expression of the Sprr gene family in 
both independent full deletion lines, 923delA and 923delB. b) In 923pdel mice, no significant changes in gene 
expression were observed as assessed by qPCR, indicating sufficiency of the remaining 238bp of the 3’ 
end of 923 for regulation of proximal gene expression. c) Immunofluorescent staining of 923 KO 
epidermal sections confirms decreased protein expression of IVL assessed by RNA-seq. d) Allele dose-
dependent decrease in Ivl expression was observed in cultured primary keratinocytes isolated from 
923delB wildtype, heterozygous, and homozygous deletion littermates, upon differentiation. Asterisk 
indicates statistical significance (p < 0.05). 
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mice displayed no significant changes in EDC gene expression, thus demonstrating that 238 bp 
of the 923 locus is sufficient for cis-regulatory gene expression (Figure 3.6b, 3.1b).  In our 
previous study, we demonstrated a requirement for a PhastCons block (highly conserved 
sequence [mouse: 20 bp, human: 23 bp]) for enhancer activity and AP-1 transcription factor 
binding (Figure 3.1b) (Oh et al. 2014). As block 1 is intact in the 923pdel-/- mice, the lack of 
gene expression differences in these mice further validates our previous findings, indicating that 
238 bp of the 923 locus that includes block 1 is sufficient for 923’s enhancer activity both in 
vitro and in vivo. 
3.3.5  Loss of 923-driven proximal gene expression results in a compensatory 
increase in the expression of Sprr gene family members 
Gene expression analysis also revealed a compensatory upregulation of Sprr gene family 
members (Sprr2a2, Sprr2e, Sprr2g, Sprr2i, Sprr2j, Sprr1b) in 923delA and 923delB -/- mice in 
comparison to wild-type littermates (Figure 3.6a). The Sprr gene family which also contains Ivl 
(de Guzman Strong et al. 2010), encodes proteins that are precursors for cornified envelope 
formation (Hohl et al. 1995). Together, our data identifies a requirement for the 923 enhancer to 
regulate proximal and distal gene expression in the EDC, the loss of which induces coordinated 
upregulation of Sprr family members to reinforce the skin barrier. 
3.4 Discussion  
Despite large, publically available datasets by the ENCODE Consortium and others that 
have identified many putative enhancers on a genome-wide scale (Kellis et al. 2014), the 
functions of these enhancers in the context of relevant tissue types remain poorly understood. 
However, while techniques exist for high-throughput screens of enhancer activity and for the 
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validation of enhancer function, these methods have relied on exogenous introduction of the 
putative enhancer to in vitro or transgenic models, and might not truly reflect the function of the 
endogenous enhancer. The advent of CRISPR-Cas9 genome editing technology has greatly 
facilitated the functional analyses of enhancers in vivo and in a more efficient and cost-effective 
manner (Guo et al. 2015; Han et al. 2015; Lupiáñez et al. 2015; Yang et al. 2016) by way of the 
relative ease of designing gRNAs to target loci. Recent studies have successfully used CRISPR-
Cas9 to introduce mutations of enhancers ranging from specific nucleotide substitutions to 
deletions over 10 Kb in a variety of human and mouse cell lines, as well as mouse models in 
order to study the roles of these enhancers (Li et al. 2014; Han et al. 2015; Zhang et al. 2016). 
Furthermore, a study employing CRISPR-Cas9 to invert CTCF binding sites within distal 
enhancers resulted in aberrant chromatin topology and gene expression (Guo et al. 2015). From 
investigating the effects of enhancers on nearby gene expression, to understanding their roles in 
maintaining the broader genomic architecture, these studies highlight the ability of the CRISPR-
Cas9 system to enable investigators to dissect the functions of non-coding elements within their 
native loci.  
Here, we apply the CRISPR/Cas9 strategy that enabled us to generate multiple alleles of 
the 923 enhancer.  Mice harboring either of the two independent deletions of 923 (923delA, 
923delB) demonstrated in nearby genes, Smcp, Lce6a, distally located Lce3 family genes (Lce3a, 
Lce3b, Lce3e and Lce3f) and Crnn, and to the greatest extent, an allele dose-dependent decrease 
in Ivl, the gene most proximal to 923. Coincident with this, we observed an upregulation of Sprr 
gene family members, Sprr2a2, Sprr2e, Sprr2g, Sprr2i, Sprr2j, and Sprr1b. However, mice with 
only a partial deletion of 923 did not display any significant alterations in gene expression, 
indicating that the remaining 923 sequence is sufficient for 923 enhancer activity. 
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The deletion of 923 resulting in the loss of proximal (Ivl, Smcp, and Lce6a) and distal 
(Lce3-family and Crnn) gene expression, while intervening Lce genes remain unaffected, is 
supported by previous studies demonstrating that subgroups of the Lce genes have distinct 
expression patterns, indicating independent modes of regulation (Marshall et al. 2001; Jackson et 
al. 2005, 2011; Niehues et al. 2016). The positions of the affected genes relative to 923, also 
suggests that 923 mediates a non-linear mechanism such as chromatin looping, to bring the 
affected genes into spatial proximity in order to regulate their expression. Our previous study 
which identified 923, also identified additional conserved non-coding elements (CNEs) with 
enhancer activity located in the vicinity of Crnn and the distal Lce3 genes (de Guzman Strong et 
al. 2010). CNE 531 located within the Lce3 gene family most distal from 923, as well as CNEs 
461 and 409 which cluster around Crnn in the Flg-like gene family, displayed significant 
enhancer activity in differentiating keratinocytes. CNEs 531, 461, and 409 all flank the boundary 
between the Lce and Flg-like gene families. A previous study observed an enrichment of 
chromatin interactions between conserved non-coding sequences, thought to be a result of their 
occupation of the same transcription factories to drive the expression of co-regulated genes 
(Robyr et al. 2011). The regulation of many EDC genes by a common core of transcription 
factors (p63, AP1, Sp1, CREB, Ezh2, C/EBP, Klf) suggest similar behavior within the EDC, 
where co-regulated genes are organized into transcription factories by regulatory elements for 
efficient gene activation.  Another study observed spatial compression of the EDC locus during 
terminal differentiation of keratinocytes, proposed to represent the looping of chromatin into an 
active chromatin structure (Fessing et al. 2011). The loss of 923 resulting in loss of expression 
from proximal genes and distal genes flanking the Lce-Flg boundary could therefore indicate the 
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loss of a chromatin interaction between 923 and enhancers in the Lce-Flg boundary region that 
normally co-regulates the genes near the two regions. 
The upregulation of the Sprr gene family in response to loss of 923/Ivl indicates a 
compensatory response to maintain the skin barrier. Ivl and the other Sprr genes form the initial 
scaffold of the cornified envelope (CE), which is the basic structural unit of the epidermal barrier 
(Kalinin et al. 2002). Previous studies have demonstrated that the Sprr genes are coordinately 
upregulated during stress, including a model of epidermal barrier deficiency resulting from the 
ablation of the Klf4 transcription factor (Patel et al. 2003). The observation that Sprr genes are 
upregulated upon the loss of 923/Ivl suggests that the normal appearance and function of the 
epidermal barrier in the 923 knockout mice is a result of a deficiency that has been compensated 
by increased quantities of other Sprr proteins. The redundancy of individual components of the 
cornified envelopes has been well demonstrated. For example, loricrin deficient mice display 
mild erythema at birth that resolves within 5 days, and fragile CEs that contain increased 
amounts of other CE proteins such as Sprr2 and repetin that compensate for the loss of loricrin 
(Koch et al. 2000).  Also, a previous study demonstrated a delayed barrier formation and 
abnormal CE ultrastructure in Ivl-Evpl-Ppl triple KO mice (Sevilla et al. 2007) compared to 
single Ivl, Evpl, and Ppl knockouts in mice that exhibited  normal skin barrier formation (Djian 
et al. 2000; Määttä et al. 2001; Aho et al. 2004), suggesting that these three genes are able to 
compensate for each other’s loss. Although the mechanism underlying the compensatory 
response is unclear, activation of Sprr genes in barrier-deficient epidermis was shown to 
correlate with an increased prevalence of DNaseI-hypersensitive sites within the locus, 
suggesting the activity of enhancers to coordinate this response (Martin et al. 2004). The 
upregulation of Sprr genes in 923 knockout mice could represent a shift from the use of a 
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preferred enhancer (923) to other nearby enhancer(s) that drive the expression of genes with 
related functions. 
Together, these studies suggest a mechanism where resident enhancers within each gene 
family mediate looping of the EDC chromatin into an active chromatin hub for easy access to a 
common pool of transcription factors. Interactions between multiple enhancers across the EDC 
would exist as a “backup system” to allow rapid activation of genes of related function to 
compensate for each other’s loss, in an organ such as the skin which is essential to survival. The 
existence of CTCF sites at the boundaries between gene families further supports the plausibility 
of this model, as CTCF has been observed to mediate the formation of chromatin loops in 
relation to gene expression (Tang et al. 2015). 
The availability of CRISPR-Cas9 genome editing has never been timelier, as it will 
enable future functional analyses of additional enhancers that may be driving gene expression in 
the skin, and allow us to elucidate the mechanisms underlying the proposed network of 
enhancers that cooperate to maintain a functional skin barrier. 
3.5 Materials and Methods 
3.5.1  Mice 
All mice were housed in pathogen-free, barrier facilities at NIH (Bethesda, MD) and Washington 
University School of Medicine (St Louis, MO). All animal procedures were approved by the 
Division of Comparative Medicine Animal Studies Committee at Washington University. All 
animal work was conducted in accordance with the Guide for the Care and Use of Laboratory 
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Animals of the National Institutes of Health. Morning observation of a vaginal plug was 
designated as embryonic day (E) 0.5. 
3.5.2  Generation of 923 alleles in mice by CRISPR/Cas9 genome editing 
To target the orthologous mouse 923 enhancer, two small guide RNAs and two ssODNs 
containing loxP sites with 80bp homology arms flanking loxP and restriction enzyme sites were 
designed to target insertion of loxP to Cas9 cut sites by homologous recombination (Integrated 
DNA Technologies, Coralville, IA).  Three rounds of injection in 779 zygotes were performed.  
Founders were initially screened for large deletions via PCR using flanking X primers 
(m923Cas9delF and m923Cas9delR) and 5’ and 3’ loxP-specific primers that were resolved on 
1% agarose gel electrophoresis. Positive candidates for loxP insertion and <1407 bp were 
subsequently cloned and Sanger sequenced. 923delA, 923delB, 923pdel and 923flox were backcrossed 
on to C57B6 mice at least 4 times and selected for the black coat phenotype to exclude potential 
off-target effects. Sequences of sgRNAs, ssODNs, and genotyping primers are listed in 
Supplementary Material. 
923delAand 923delB: Primers flank entire region. Larger region deleted in 923delB. Same primers 
identified 923pdel due to partial deletion. 
5’ loxP: Left primer on upstream sequence, right primer on junction of 5’ loxP and 923. 
3’ loxP; Left primer on junction of 923 and 3’ loxP, right primer on downstream sequence. 
3.5.3  Histology and Immunohistochemistry 
Dorsal skin was excised from newborn mice and frozen in OCT compound prior to 
cryosectioning. Dorsal skin was excised from 8 week old mice and preserved in 4% 
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paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA) prior to paraffin sectioning. 
Sections were stained with hematoxylin and eosin (H&E) by the Washington University 
Developmental Biology Histology Core. H&E stained sections were imaged on a Nikon Eclipse 
80i brightfield microscope (Nikon, Tokyo, Japan).  
Primary antibodies used for immunofluorescence are rabbit IVL (4b-KSCN, 1:200) and chicken 
K14 (5560, 1:500) (courtesy of J. Segre). Secondary antibodies used were goat anti-rabbit (Alexa 
Fluor 488, 1:500) and goat anti-chicken (Alexa Fluor 594, 1:500) IgG antibodies (Life 
Technologies, Frederick, MD). Sections were fixed in 4% paraformaldehyde (Electron 
Microscopy Sciences, Hatfield, PA) prior to permeabilization with 0.1% Triton X-100 and 
subsequent antibody incubation. Sections were counterstained with SlowFade Gold antifade 
reagent with DAPI (Life Technologies, Frederick, MD) prior to fluorescent imaging. 
3.5.4  RNA analyses 
Total RNA was isolated by TriZol extraction (Life Technologies, Frederick, MD) from 
epidermal isolates preserved in RNALater (Thermo Fisher Scientific, Waltham, MA).  
Real-time qPCR on cDNA (generated using SuperScript II reverse transcriptase (Thermo Fisher 
Scientific)) using SYBR Green was performed in triplicate (Fast SYBR Green Master Mix ABI 
ViiA7, Thermo Fisher Scientific) and normalized to β2-microglobulin. Only CT values with 
single peaks on melt-curve analyses were included. Primers are listed in the supplementary 
material. RT-qPCR was performed on at least 2 individuals per genotype.  
RNA-seq was performed on ribosome-depleted RNA libraries that were single-read sequenced 
on Illumina HiSeq3000 and analyzed by the Washington University Genome Technology Access 
Center (GTAC). Differential expression was determined based on normalization to the E14.5 
 
 
71 
developmental time point, with one individual from each independent deletion line (923delA, 
923delB) representing biological replicates. Differential expression values corresponding to Figure 
3.6a are listed in the Supplementary Material.  
3.5.5  Dye penetration barrier assays 
Mouse embryos were incubated in an X-gal solution for at least 4 hours at 37°C. The embryos 
were imaged on a CanoScan 5600F scanner (Canon, Melville, NY) to determine the extent and 
location of skin barrier formation. 
3.5.6  Cornified envelope preparations 
Skin was taken from newborn and postnatal day 1 mice and floated on 0.25% Trypsin to allow 
dissociation of the epidermis from the dermis. An approximately 1cm2 piece of epidermis was 
incubated at 95°C in a solution of 2% SDS to obtain cornified envelopes in a single-cell 
suspension. The suspension was placed on a slide and examined using phase contrast light 
microscopy on a Zeiss Axiovert 40 CFL (Carl Zeiss, Stockholm, Sweden). Images were captured 
with Zeiss AxioCam ERc 5s using Zeiss ZEN software (Carl Zeiss, Stockholm, Sweden). 
3.6 Supplementary Material 
Supplementary material can be viewed in Appendix B. 
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Chapter 4 
 
Genome-wide Chromatin Architecture of the 
EDC 
4.1 Abstract 
Enhancers are known to drive tissue-specific gene expression by forming physical interactions 
by chromatin looping with the gene promoters. Epidermal enhancer 923 was previously shown to 
interact with several EDC gene promoters selectively assayed in the context of epidermal 
development. However, we do not fully understand the extent to which 923 is involved in the 
chromatin architecture underlying expression of EDC and other genes essential for epidermal 
development. Here, I sought to determine the chromatin architecture within and surrounding the 
EDC, pertaining to keratinocyte differentiation. I approached this by using large-scale high-
throughput chromosome conformation capture assays (4C-seq) to identify the keratinocyte-
specific chromatin interactions with respect to 2 viewpoints in the EDC, the 923 enhancer and 
Flg promoter. A marked decrease in interaction frequencies beyond the EDC in all EDC-
viewpoint libraries supports the notion of a topologically associated domain encompassing the 
EDC. Within the EDC, I identified an enrichment of interactions for the 923 enhancer with the 
Sprr and Lce gene families in the keratinocytes compared to the P5424 T-cell line that does not 
express EDC genes. Keratinocyte-specific enrichment of interactions was observed between each 
of the 923 enhancer and Flg promoter with the gene desert located between the S100 and Sprr 
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families. Of note was a proliferating keratinocyte-specific interaction between 923 and a 
previously identified enhancer (CNE 531) near the Crct1 gene. In addition, the Flg viewpoint 
displayed a differentiated keratinocyte-specific enrichment of interactions with the region 
between Hrnr and Rptn containing previously identified enhancer CNE 184. Trans-interactions 
enriched in keratinocytes were identified with non-EDC genes that are important for epidermal 
function including Trp63, an important regulator of keratinocyte differentiation. Together, my 
results identify a network of biologically relevant chromatin loops to the EDC to include 
enhancer-gene interactions in cis and in trans as well as enhancer-enhancer interactions. The 
evidence for chromatin architecture involving the EDC and other loci important for epidermal 
function further supports the notion of a “form follows function” principle for keratinocyte-
specific gene expression. 
 4.2 Introduction 
As described in Chapter 1, epidermal development involves the coordinated expression of 
many genes including the EDC genes, the keratins, desmogleins, and plakins. The regulation of 
these genes requires the binding of many of the same transcription factors (TFs) such as AP-1, 
KLF, and CEBP, to proximal and distal enhancers to drive their tissue-specific gene expression. 
While the importance of these individual components is known, the precise mechanisms by 
which they cooperate to drive such coordinate expression are not well understood. Investigations 
into the chromatin architecture surrounding an active gene or enhancer will provide insights 
about the molecular mechanisms that drive gene expression in a cell or tissue-specific manner. A 
recent analysis leveraged a focused high-resolution 3C variant known as chromosome 
conformation capture carbon-copy (5C) to investigate the relationship between the chromatin 
architecture and expression of the CFTR locus in a variety of cell types (Smith et al. 2016). 
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Based on the 5C interactions, they identified a region spanning the locus known as a 
topologically associated domain (TAD), where there was a high frequency of chromatin 
interactions within the TAD, and lower interaction frequencies with regions outside the TAD. 
The TADs and their boundaries were consistent across different cell-types. However, cell-
specific gene expression coincided with cell-type-specific enhancer-promoter interactions within 
TADs, as well as cell-type-specific interactions between TADs that tended to involve loci 
clustered around TAD boundaries. This suggested that the key to elucidating the molecular 
mechanisms driving cell-specific expression lies in the analysis of cell-specific chromatin 
interactions. Additional studies have also definitively established a role for CTCF to maintain the 
boundaries of these TADs, thereby allowing genes that are close on the linear genome, but 
residents of neighboring TADs, to have different gene expression patterns (Guo et al. 2015; 
Lupiáñez et al. 2015; Yang et al. 2016).  
Within the β-globin locus, temporal control of gene expression is a result of the 
organization of active chromatin hubs (ACH) by CTCF-mediated loops (TADs) and enhancer-
gene interactions (Palstra et al. 2003). These studies in conjunction with ENCODE-annotated 
CTCF binding sites led me to hypothesize the existence of one or more TADs within the EDC. 
These TADs and the enhancer-promoter interactions within would thus form an ACH to mediate 
the concomitant activation of EDC genes brought into proximity with the enhancers during 
keratinocyte differentiation. Furthermore, intra-chromosomal (cis) and inter-chromosomal (trans) 
interactions revealed spatial association of the active globin genes with other co-regulated genes 
at “transcription factories”, and found that the transcription factor KLF1 was necessary for 
mediating the associations of KLF1 co-regulated genes (Schoenfelder et al. 2010). Given that the 
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same transcription factors regulate many of the co-expressed genes essential for epidermal 
differentiation, it seems likely that the EDC participates in such a transcription factory.  
In Chapter 2, the characterization of 923’s enhancer function revealed physical chromatin 
interactions between 923 and several of the EDC gene promoters. This was determined using 
low-throughput chromosome conformation capture assays (3C) that depend on PCR-based 
identification of individual ligation junctions. 3C is a very targeted approach that provides a 
limited view of all possible interactions in which a single genomic region might be a participant. 
It requires prior knowledge, or a strong suspicion, of the existence of an interaction in order for 
primers to be designed for the amplification of specific targets. The evidence of 923’s enhancer 
activity described in Chapters 2 and 3 suggests a pivotal role for 923 in mediating the chromatin 
architecture of the EDC. Further interrogation of 923 will provide a more detailed view of its 
interactions within the EDC as well as a unique viewpoint for enhancer-centric EDC contacts 
with other loci. Given my previous work and the prior studies, I hypothesized that 923 formed 
both cis-interactions representing enhancer-promoter contacts within an EDC TAD or ACH and 
trans-interactions representing an epidermal differentiation transcription factory, in a 
keratinocyte-specific manner.  
To capture genome-wide chromatin interactions with the EDC, I performed the circular 
chromosomal conformation capture assay coupled with next-generation sequencing (4C-seq) 
(Splinter et al. 2012), with respect to the 923 enhancer and the Flg promoter in proliferating 
keratinocytes, differentiating keratinocytes, and P5424 T-cells. The T-cells do not express EDC 
genes and thus provide background interaction frequencies for an inactive EDC locus. I aimed to 
discover chromatin interactions with the Flg promoter as coding mutations have been identified 
in ichthyosis vulgaris and atopic dermatitis, diseases with a component of skin barrier deficiency 
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component (Irvine and McLean 2006; Palmer et al. 2006; Smith et al. 2006; Nomura et al. 2009), 
but little is known about the enhancers that regulate FLG. 4C-seq is a variation of 3C that in 
theory detects “all” chromatin looping events for a specific “viewpoint” or “bait” sequence of 
interest. Thus, I sought to identify 923 enhancer- and Flg promoter-mediated chromatin 
interactions specific to keratinocytes that define both “within-TAD” cis-interactions and 
“between-TAD” trans-interactions.  
The 4C strategy will enable me to 1) gain a genome-wide view of the native chromatin 
architecture mediated by 923 and the Flg promoter underlying normal keratinocyte 
differentiation, and 2) potentially identify cis- or trans-acting regulatory elements for Flg gene 
expression 
4.3 Results 
4.3.1  Generation and sequencing of 4C-seq libraries 
4C-seq libraries were generated from proliferating and differentiated mouse primary 
keratinocytes with 3 biological replicates per condition/cell-type.  Specifically, the 4C-seq 
libraries were derived from the same cells used in my previously cross-linked 3C experiments 
described in Chapter 2. To establish a background frequency of non-keratinocyte-specific 
interactions, I also generated libraries from the P5424 RAG1−/−, p53−/− pro-T-cell line. In 
addition to the 923 and Flg gene promoter viewpoints, I included the Eβ enhancer with known 
interactions within the Tcrb locus in the P5424 T-cells as a technical control for the 4C-seq 
technique (Oestreich et al. 2006).  
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The 4C-seq libraries were created as previously described (Splinter et al. 2012, see also 
Methods). However, I wanted to ensure enough unique reads to maximize mappability of the 
interacting sequences. Thus, I devised a unique strategy to increase the number of informative 
bases in the sequencing reads (interacting sequences) in my 4C-seq libraries. Instead of adding 
standard Illumina sequencing adaptor tails to the 4C amplicons, I designed custom nested index 
PCR primers to bind within the viewpoint or bait (923 or Flg) as close as possible to the 
restriction site junction with the interacting sequence (Fig. 4.1). This also necessitated the use of 
custom sequencing primers (Table S1). I successfully generated 4C-seq libraries from 
proliferating and differentiated mouse primary keratinocytes based on optimal digestion using 
HindIII (first digest) and NlaIII  (second digest) restriction enzymes (>80% digestion assessed by 
qPCR across the restriction sites flanking the viewpoint fragment). I determined both efficient 
ligation (formation of high molecular weight products), and successful synthesis of nested PCR 
amplicons, by agarose gel electrophoresis (Fig. S1). The 21 4C-seq libraries were pooled and 
then sequenced on two lanes of an Illumina Hi-Seq 2500 to obtain 50 bp single-end reads. The 
use of two lanes represent technical replicates to account for batch effects.  
4.3.2  Quality assessment of 4C sequencing data 
The raw sequencing reads were initially demultiplexed by allowing for 1 mismatch for 
each of the index sequences and subsequently binned into the corresponding library, with a range 
of 47,000 reads – 6.2 million reads per library in one lane (lane 6), and 43,000 reads – 6.9 
million reads per library in the second lane (lane 7) (Fig. S2). Many of the reads, 62 million 
(52%) from lane 6 and 58 million (46%) from lane 7, could not be assigned to any of the 
libraries. The demultiplexed reads were mapped to a “fragment end library” consisting of a 
reduced genome containing only genomic sequences flanking the recognition sites of the 
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restriction enzymes used in the experiment (HindIII and NlaIII), and limited only to fragments 
flanked by one HindIII and one NlaIII  site (Splinter et al. 2012). Visual inspection of the 
demultiplexed RPM normalized reads in the UCSC genome browser revealed unexpectedly that  
!
 
Figure 4.1. Custom primers for 4C-seq library preparation. Custom nested and indexed primers were 
designed to amplify off the inverse PCR product, as close as possible to the bait-interactor ligation 
junctions as possible. Primers for all libraries utilizing the same viewpoint are identical, except the index 
sequences on the reverse primer which are unique for each library. Libraries were submitted for 
sequencing with custom sequencing and index read primers. 
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in one of the Flg promoter viewpoint P5424 T-cell libraries, the region surrounding 923 
contained the highest frequency of reads (Fig. S3). Since 4C experiments characteristically 
display the highest interaction frequencies close to the viewpoint fragment and decrease with 
increasing distance (Splinter et al. 2012), this unusual distribution of interactions suggested 
contamination of reads between the libraries. I hypothesized that this was due to the 
misassignment of reads during the demultiplexing process, and meant that any attempt at 
identification of significant interactions would most likely produce many false positives.  
In order to increase stringency, I repeated the demultiplexing of the 4C-seq data to allow 
exact matches (0 mismatches) for each of the index sequences. As a result, the number of reads 
mapped to each library decreased to 5315 reads - 4.4 million reads/library (lane 6) and 6535 
reads - 4.8 million reads/library (lane 7), with an increase in the number of unassignable reads to 
81 million (68%) and 82 million (65%) respectively (Fig. S2). Again, the demultiplexed reads 
were mapped to the reduced genome as before. Visual inspection of the 0 mismatch 
demultiplexed RPM normalized reads in the UCSC genome browser revealed that the unusual 
peak previously observed near 923 in the Flg viewpoint P5424 T-cell libraries was no longer 
present (Fig. S3). Instead, each library now displayed the expected interaction pattern where the 
greatest number of reads mapped to the region close to its respective viewpoint (Fig. S3, S4, S5). 
This finding confirmed that the increased reads mapping to the 923 viewpoint in a library for the 
Flg viewpoint stemmed from reads obtained from an improper assignment of reads belonging to 
a 923 viewpoint library. The 1.4 – 10-fold loss in the number of reads resulting from the more 
stringent demultiplexing meant that the sparse coverage achieved in most of the libraries was 
prohibitive to the method of analyzing 4C that relies on identifying regions that are significantly 
over-represented relative to the neighboring regions (Splinter et al. 2012). Nevertheless, using 
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the 0 mismatch demultiplexed libraries, each of the two lanes produced 11 out of 21 libraries 
with sufficient 4C library quality (>40% cis-interactions, >1 million reads) for further analysis 
for the identification of keratinocyte specific cis- and trans-interactions (Fig. S6, Table S2) (van 
de Werken et al. 2012). From each lane, one out of three biological replicates of the 923 
viewpoint differentiating keratinocyte libraries (923 KerD), Flg viewpoint proliferating 
keratinocyte libraries (Flg KerP), and Flg viewpoint differentiating keratinocyte libraries (Flg 
KerD), two out of three biological replicates of the 923 viewpoint P5424 T-cell libraries (923 
Tcells) and Flg viewpoint P5424 T-cell libraries (Flg Tcells), and all three biological replicates 
of the Eβ enhancer viewpoint P5424 T-cell libraries (Eβ Tcells) had passed the quality threshold 
defined earlier. None of the 923 viewpoint proliferating keratinocyte libraries (923 KerP) 
surpassed the quality threshold, but one replicate that fell just short of the threshold was included 
in the downstream analyses for the purpose of completeness. 
4.3.3  4C-seq identifies the EDC as a topologically associated domain  
4C-seq libraries that passed the quality threshold as defined above were visualized on the 
UCSC Genome Browser using RPM-normalized reads, and represent chromatin interaction 
profiles in proliferating keratinocytes, differentiating keratinocytes and P5424 T-cells. In each of 
these libraries, the peak height at each mapped position corresponds to the number of reads per 
million (RPM) at that position, and represents the frequency of chromatin interactions between 
the viewpoint in question and the fragment to which the read belongs. The interaction profiles 
demonstrate the characteristic interaction frequencies that are highest in the regions closest to the 
respective viewpoints, and decline with increasing distance from the viewpoint (Fig. 4.2). The 
923 and Flg promoter viewpoint in keratinocyte libraries showed a marked decline in the 
frequencies of interactions that occur within a 5Mb domain surrounding the EDC (S100a1 –  
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a 
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Figure 4.2. 4C-seq reveals an EDC TAD and an enrichment of EDC reads in keratinocyte libraries. 
After RPM normalization, peaks remain visible in the keratinocyte 4C libraries after subtracting T-cell 
reads, indicating an enrichment of interactions within the EDC in keratinocytes with both the a) 923 and 
b) Flg viewpoints.  
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S100a10) and demarcated by neighboring genes Rps27 and Gabp2 (Fig. 4.2). There also 
appeared to be localized peaks within the EDC indicating an overrepresentation of interactions in 
specific regions of the EDC. While interactions existed beyond the EDC, these were rare and 
sparse. These observed chromatin interactions in keratinocytes suggest a compact chromatin  
structure within the bounds of Rps27 and Gabp2, specific interactions within this structure, and 
obstacles to interactions with regions outside this 5Mb domain. On the other hand, the T-cell 
libraries representing an inactive EDC showed a more gradual decrease in interaction frequencies 
that appeared to decline as a function of distance. Beyond the boundaries of the locus marked by 
Rps27 and Gabp2, there was a low, albeit evenly distributed frequency of interactions (Fig. 4.2). 
This suggested a chromatin conformation of the EDC locus in T-cells that is absent of the 
specific interactions within the chromatin structure that were observed in the keratinocytes. 
Together, these observations indicate an EDC TAD that appear to exhibit similar 
boundaries where interactions are more frequent within the TAD and less frequent outside the 
TAD, regardless of cell-type. Within the TAD in keratinocytes, however, there appear to be cell-
specific interactions.  
4.3.4 Keratinocyte-specific cis-interactions with the 923 enhancer and Flg 
promoter were observed within the EDC 
The distribution of 4C-seq reads revealed distinct regions for which there were 
observable increased interactions frequencies that were specific to either keratinocytes compared 
to T cells (Fig 4.2). Thus, to identify chromatin interactions for the 923 enhancer and the Flg 
promoter within the EDC that were enriched specifically in keratinocytes, I subtracted 4C-seq 
reads obtained from the T-cells that represent the “background”. This approach to identify 
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keratinocyte-specific chromatin interactions with either the 923 enhancer or the Flg promoter 
enables a more focused investigation on key chromatin interactions but does not completely 
exclude the importance of genomic regions associated with fewer reads for interactions. I also 
used the MACS peak caller to identify regions where 4C-seq reads for the 923 enhancer and Flg 
promoter were enriched in the keratinocytes compared to the P5424 T-cells (Feng et al. 2012).  
The numbers of regions containing keratinocyte-enriched 4C-seq reads based on 
subtracting the background T-cell reads within the EDC are listed in Table 4.1. As shown in 
Table 4.2, which lists a subset of the reads accounted for in Table 4.1, only a small number of the 
keratinocyte-enriched 4C-seq reads overlap annotated regulatory elements. Interestingly, several 
of the keratinocyte-enriched 4C-seq reads correspond to annotated Cdx1 transcription factor 
binding sites (Lesurf et al. 2016) (Table 4.2). Cdx1 does not have a known role in keratinocyte 
differentiation, but is important for regulating the differentiation of gastrointestinal epithelia 
(Chan et al. 2009). The identification of an annotated binding site for Jarid2, Suz12, EZH2, Mtf2 
within exon 2 of the Tchh gene (Table 4.2, UCSC mm10: chr3: 93443451-93443501) was 
particularly interesting since Jarid2, Suz12, and EZH2 are Polycomb group proteins that are 
important for epigenetic regulation of keratinocyte function (Eckert et al. 2011; Botchkarev et al. 
2012), and Mtf2 has been known to complex with Polycomb Repressive Complex 2 (Li et al. 
2010). Another region (Table 4.2, chr3:93,015,655-93,015,705), containing 4C-seq reads 
enriched specifically in the 923 viewpoint proliferating keratinocytes, overlaps the Crct gene. 
This region is orthologous to a previously identified CNE in the human genome, 531, that 
demonstrated enhancer activity in an in vitro reporter assay (de Guzman Strong et al. 2010).  
A keratinocyte-specific enrichment of 4C-seq reads was also identified in both 
proliferating and differentiating keratinocytes within the 1.3 Mb gene desert that separates the  
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Table 4.1.  Numbers of enriched 4C-seq reads in keratinocyte libraries based on 
subtraction of T-cell reads.  
Gene!family! Enriched!in!library!
923!KerD! 923!KerP! Flg!KerD! Flg!KerP!
S100!5'! 3! 5! 13! 11!
Gene!desert! 38! 21! 70! 102!
Pglyrp3! 2! 0! 6! 7!
Sprr! 15! 5! 36! 42!
Between!Sprr!and!Lce! 2! 0! 1! 5!
Lce! 11! 12! 18! 24!
Between!Lce!and!Flg! 5! 4! 10! 2!
Flg! 17! 14! 30! 3!
Between!Flg!and!S100!3'! 0! 1! 2! 1!
S100!3'! 1! 2! 2! 0!
 
 
Table 4.2. Regulatory element annotations of enriched 4C-seq reads in keratinocyte 
libraries based on subtraction of T-cell reads.  
Genomic!position! Enriched!in!
library! Annotated!Function!(Lesurf!et!al.!2016)!
Chr! Start! End!
chr3 92303052! 92303102! 923!KerD! Cdx1!binding!site!upstream!of!Sprr2b!
chr3 93443451! 93443501!
923!KerP,!
Flg!KerD!
Jarid2,!Suz12,!EZH2,!Mtf2!binding!site!
overlapping!Tchh)exon!2!
chr3 91203067! 91203117!
Flg!KerD,!
Flg!KerP! Cdx1!binding!site!in!gene!desert!
chr3 91262658! 91262708!
Flg!KerD,!
Flg!KerP! Cdx1!binding!site!in!gene!desert!
chr3 93015655! 93015705! 923!KerP!
Functional!conserved!regulatory!element!
CNE!531!(de!Guzman!Strong!et!al.!2010)!
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S100 and Sprr gene families (Fig. 4.2a). In the 923 viewpoint proliferating keratinocyte library, 
one enriched region was located approximately 520 kb downstream from the S100a9 gene (~800 
kb upstream from Pglyrp3) (UCSC mm10: chr3:91,216,458-91,216,507), while one was 
observed in the differentiating keratinocytes approximately 780 kb downstream from S100a9 
(~540 kb upstream from Pglyrp3) (chr3: 91,471,110-91,471,159). With the Flg promoter 
viewpoint (Fig. 4.2b), the proliferating keratinocytes, showed an enriched region approximately 
370 kb downstream from the S100a9 gene (~950 kb upstream from Pglyrp3) (chr3: 91065728-
91065777), while several were observed in the differentiating keratinocytes at approximately 185 
kb, 540 kb, 760 kb, and 700 kb from S100a9 (1135 kb, 780 kb, 560 kb, and 520 kb from 
Pglyrp3) (chr3:90880868-90880917, chr3: 91138413-91138462, chr3: 91230604-91230653, 
chr3: 91272119-91272168). The enrichment of reads within the gene desert might indicate as yet 
unannotated regulatory elements, or might be an artifact of the chromatin architecture of the rest 
of the EDC locus. The differentiated keratinocytes also showed specific enrichment of 
interactions between the Flg promoter and regions across the Flg, Lce, and Sprr gene families 
(Fig. 4.2b). One of these interaction peaks in particular lies between Hrnr and Rptn, in a region 
orthologous to a human EDC region harboring a cluster of previously identified CNEs (180, 184, 
and 189) with demonstrated regulatory activity in vitro (de Guzman Strong et al. 2010). Thus, I 
identified chromatin interactions between the 923 enhancer and the Flg promoter that correlate to 
functional regulatory elements in keratinocytes and suggests a potential role in these specific 
looping events for functional gene activation. 
To determine the biological relevance of the chromatin interactions, I subsequently 
interrogated the MACS peaks using the Genomic Regions Enrichment of Annotations Tool 
(GREAT).   Specifically, GREAT assigned potential biological functions to the regions where 
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4C-seq reads were enriched in keratinocytes relative to T-cells (McLean et al. 2010). Tables S3 – 
S6 list all Gene Ontology (GO) associations that achieve a significance threshold of binomial 
FDR <0.05, ranked in decreasing order of significance (smallest binomial FDR to largest 
binomial FDR). EDC genes are listed in bold. 
This analysis identified an enrichment of 4C-seq reads in close proximity to genes 
associated with epidermal development-related GO terms (Table 4.3, Table 4.4). Keratinization, 
cornified envelope, and keratinocyte differentiation were the top three GO terms (based on FDR) 
for the 923 KerD (Table 4.3, Table S3). Cornified envelope was the top GO term associated with 
interactions enriched in Flg KerD, with keratinization, keratinocyte differentiation, epidermal 
cell differentiation, epidermis development, skin development, and structural constituent of 
epidermis achieving significance as well (Table 4.4, Table S4). This was consistent with the 
established role of Flg as an important keratinocyte differentiation gene, as well as 923’s role in 
regulating key structural genes such as Ivl. In the Flg KerD library. Enriched reads were found in 
the Flg, Sprr (including Ivl), Lce, and S100 gene families (Table 4.4, Table S5), placing the Flg 
promoter within a network of chromatin interactions extending all across the EDC. In the 923 
KerD library, most of the enriched reads were found within the Sprr gene family (Table 4.3, 
Table S3), indicating that within the EDC, the 923 enhancer mediates chromatin interactions 
mainly localized to the Sprr gene family to which it belongs. Considering the proximity of 923 to 
the Ivl gene, the absence of reciprocity between the 923 viewpoint and Flg was surprising, but 
could be due to the smaller number of reads obtained from the 923 KerD library.  
The GREAT analysis also identified an enrichment of 4C-seq reads in both the 923 KerD 
(Table S3) and Flg KerD (Table S5) libraries near genes associated with detection and defense 
responses to bacteria, including GO terms such as peptidoglycan receptor activity and detection  
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Table 4.3. GREAT-predicted cis-regulatory targets of 4C-seq reads enriched in 923 enhancer viewpoint differentiating 
keratinocytes (923 KerD) relative to T-cells. 
ID# Desc# BinomFdrQ# Genes#
GO:0031424) keratinization) 2.60E614) Ivl,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2i,Sprr3,Sprr4#
GO:0001533) cornified)envelope) 2.67E614) Ivl,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2i#
GO:0030216)
keratinocyte)
differentiation) 3.35E605) Ivl,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2i,Sprr3,Sprr4,Yap1#
 
Table 4.4. GREAT-predicted cis-regulatory targets of 4C-seq reads enriched in Flg promoter viewpoint differentiating 
keratinocytes (Flg KerD) relative to T-cells. 
ID# Desc# BinomFdrQ# Genes#
GO:0001533) cornified)envelope) 4.89E618) Anxa1,Flg,Hrnr,Ivl,Lor,Rptn,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i#
GO:0031424) keratinization) 3.83E613) Abca12,Hrnr,Ivl,Lor,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Sprr4)
GO:0030216)
keratinocyte)
differentiation)) 2.29E605)
Abca12,Anxa1,Ctnnd1,Hrnr,Ivl,Lor,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Spr
r4,Trp63)
GO:0009913)
epidermal)cell)
differentiation) 2.45E603)
Abca12,Anxa1,Atoh1,Clic5,Clrn1,Ctnnd1,Ercc3,Gli2,Grxcr1,Hdac2,Hrnr,Ivl,Lor,Myo7a,Pcdh15,Slitrk6,Sprr1
b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Sprr4,Trp63)
GO:0008544)
epidermis)
development) 1.68E602)
Abca12,Anxa1,Atoh1,Barx2,Clic5,Clrn1,Ctnnd1,Ercc3,Flg,Foxq1,Gli2,Grxcr1,Hdac2,Hrnr,Igf1r,Inhba,Ivl,Lce
1g,Lce1i,Lce1l,Lce1m,Lce3a,Lce3c,Lce3f,Lor,Myo7a,Pcdh15,Pdgfa,Pou3f2,Slitrk6,Sprr1b,Sprr2a1,Sprr2a2,
Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Sprr4,Tgfb2,Trp63)
GO:0043588) skin)development) 2.18E602)
Abca12,Anxa1,Arrdc3,Atoh1,Barx2,Clic5,Clrn1,Col1a1,Col1a2,Ctnnd1,Ercc3,Flg,Foxq1,Gli2,Grxcr1,Hdac2,H
rnr,Igf1r,Inhba,Ivl,Lce1g,Lce1i,Lce1l,Lce1m,Lce3a,Lce3c,Lce3f,Lor,Myo7a,Pcdh15,Pdgfa,Pou3f2,Slitrk5,Slit
rk6,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Sprr4,Tcf7l2,Tgfb2,Trp63)
GO:0030280)
structural)
constituent)of)
epidermis) 3.82E602) Lor#
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of bacterium. A closer look revealed that this was the result of an enrichment of 4C-seq reads 
within the gene desert which are associated with flanking genes Pglyrp3 and Pglyrp4, and 
correspond to the enriched reads that had been identified in the gene desert by subtracting the 
background T-cell reads.  
4.3.5 Keratinocyte-specific trans-interactions with the 923 enhancer and Flg 
promoter were observed near epidermal differentiation genes 
The results of the MACS peak calling and subsequent GREAT analysis were also used to 
predict the functional significance of trans-interactions for the EDC in keratinocytes. 
Interestingly, within both 923 KerP and Flg KerP libraries, there were shared enrichments of 4C-
seq reads relative to T-cells near Vmn1r family genes related to pheromone receptor activity 
(Tables S4 and S6). The Flg KerP libraries also displayed an enrichment of 4C-seq reads near 
genes belonging to the Olfr family (Table S6). Although the expression of the Olfr genes was 
originally thought to be limited to sensory neurons in the olfactory nasal epithelium, studies have 
indicated roles for the Olfr genes in other epithelial tissues (Gu et al. 2014). Therefore, the 
identification of 4C-seq reads near Olfr aside from the Vmn1r genes with respect to the EDC, 
could represent spatial proximity of these loci within a nuclear compartment for gene regulatory 
crosstalk. 
I decided to focus on trans-interactions that would be most relevant to understanding the 
genome-wide interactions mediated by 923 and the Flg promoter in the context of keratinocyte 
differentiation by only considering MACS peaks that were associated with significantly enriched 
GO terms keratinocyte differentiation, keratinization, and cornified envelope, as determined by 
GREAT (Tables 4.3 and 4.4). These included an interaction between the 923 enhancer and 
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genomic fragments neighboring Yap1 in differentiating keratinocytes, associated with the GO 
annotation of keratinocyte differentiation (Table 4.3, Table 4.5, Fig. 4.3). As well, MACS 
identified trans interactions between the Flg promoter with genomic regions near Abca12, 
Anxa1, Ctnnd1, and Trp63 (Table 4.4, Table 4.6). Interestingly, Trp63, encodes p63, which is an 
important regulator of epidermal differentiation (Fig. 4.4). The identification of interactions with 
important epidermal differentiation genes on other chromosomes suggests possible co-regulation 
of Flg and 923-regulated genes by a wider network of chromatin interactions that extends 
beyond the EDC. However, additional experiments will need to be performed in the future to 
validate these findings.  
4.4 Discussion  
In summary, my results identify similar EDC TADs in proliferating versus differentiated 
keratinocytes and P5424 T-cells, consistent with the earlier studies that noted invariant TAD 
boundaries regardless of cell-type (Smith et al. 2016). However, within the boundaries of the 
EDC TAD, the keratinocyte libraries appeared to also contain distinctive peaks in interactions 
compared to the T-cells, likely representing interactions specific to an active EDC locus. Using 
3D-FISH, a previous study demonstrated keratinocyte-specific compression of the EDC locus 
mediated by chromatin remodeler, Satb1, and predicted that Satb1 regulates EDC gene 
expression by forming a densely looped chromatin structure (Fessing et al. 2011).  A related 
study further demonstrated that low EDC gene expression was correlated with distal positioning 
of the EDC from the neighboring genes Rps27 and Gabp2, while high EDC expression 
correlated with proximity between the EDC and Rps27 and Gabp2 (Mardaryev et al. 2013). 
Using 923- and Flg-centric 4C-seq as independent functional assays for the chromatin 
architecture of the EDC, I identified a similar topology within the EDC that is unique to  
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Table 4.5. 4C-identified trans-interactions.  
Bait Target Function 
923 Yap1 Modulator of epidermal stem cell proliferation 
Flg 
Abca12 
Keratinocyte lipid transporter, important for maintaining epidermal 
lipid barrier 
Anxa1 
Interacts with S100A11 in epidermal growth factor-triggered 
growth signal pathway 
Ctnnd1 Important for cell adhesion 
Trp63 Master regulator of keratinocyte differentiation 
 
 
 
 
 
Figure 4.3. Keratinocyte-specific chromatin interactions identified between the 923 enhancer and 
Yap1. Example of a MACS-called significant interaction in 923 viewpoint differentiating keratinocyte 
library relative to T-cells. A 4C interaction with 923 mapped to a genomic region near Yap1 and was 
identified by MACS as significantly enriched in a differentiating keratinocyte library relative to a T-cell 
library. 
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Figure 4.4. Keratinocyte-specific chromatin interactions identified between the Flg promoter and 
Trp63. Example of a MACS-called significant interaction in the Flg promoter viewpoint differentiating 
keratinocyte library relative to T-cells. A 4C interaction with the Flg promoter mapped to a genomic 
region near Trp63 and was identified by MACS as significantly enriched in a differentiating keratinocyte 
library relative to a T-cell library. 
 
Table 4.6.  Numbers of enriched 4C-seq reads in keratinocyte libraries relative to T-cells based on 
MACS peak calls. 
Gene$family$
Enriched$in$library$
923$KerD$ 923$KerP$ Flg$KerD$ Flg$KerP$
S100$5'$ 0$ 0$ 2$ 0$
Gene$desert$ 6$ 1$ 13$ 1$
Pglyrp3$ 0$ 0$ 3$ 0$
Sprr$ 21$ 1$ 10$ 2$
Between$Sprr$and$Lce$ 0$ 0$ 1$ 0$
Lce$ 3$ 3$ 7$ 0$
Between$Lce$and$Flg$ 0$ 0$ 8$ 0$
Flg$ 0$ 0$ 22$ 3$
Between$Flg$and$S100$3'$ 0$ 0$ 1$ 0$
S100$3'$ 0$ 0$ 2$ 0$
Scale
chr16:
100 kb mm10
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keratinocytes compared to T-cells that do not express the EDC genes. The EDC cis-interactions 
identified by subtraction of T-cell reads indicated that both 923 and the Flg promoter were 
capable of forming interactions throughout the EDC (Table 4.1). This method identified cis-
interaction profiles that encompass similar regions with respect to both 923 and Flg baits, 
providing further evidence for the EDC chromatin domain identified in the previous studies 
(Fessing et al. 2011; Mardaryev et al. 2013). However, the more stringent MACS peak caller 
indicated that 923, formed more localized interactions mainly within the Sprr gene family and 
the nearby Lce family, while the Flg promoter displayed a more far-reaching interactions, 
extending throughout the EDC (Table 4.6).  
The identification of chromatin looping events within the gene desert for both 923 and 
Flg loci suggests the co-opting of a regulatory element by both a gene and an enhancer. The 
chromatin looping events between 923 and CNE 531 enhancer support the tendency for 
regulatory elements to interact with each other, as previously noted (Robyr et al. 2011). The 
interactions between the Flg promoter and the gene desert, as well as the region harboring CNE 
enhancers 180, 184, and 189, also illustrate the use of 4C-seq data to discover putative functional 
regulatory elements for chromatin remodeling.  
Recent studies have identified specific roles for CTCF to mediate chromatin architecture 
and gene expression. Depletion of the structural proteins CTCF and cohesin and the deletion of 
CTCF binding sites and a cis-regulatory element identified that while CTCF binding was 
necessary for maintaining a normal interaction profile, the regulatory element was required for 
normal gene expression (Yang et al. 2016). Additional studies definitively demonstrated that the 
deletion of a CTCF site, can alter the TAD structure caused aberrant enhancer-promoter 
interactions and thus aberrant gene expression (Guo et al. 2015; Lupiáñez et al. 2015). Consistent 
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with these findings, ENCODE-annotated clusters of CTCF binding sites are found between each 
of the 4 EDC gene families and suggest that up to 4 TADs may exist within the EDC (Fig. 4.5). 
The locations of the CTCF sites are largely conserved across a variety of tissues and cell-types, 
indicating a conservation of TADs. 
Interestingly, the human orthologous region (UCSC hg38 chr1:152,162,963-152,173,456) 
for the approximate 12 kb region (UCSC mm10 chr3: 93,376,723-93,389,039) that interacts with 
the Flg promoter also encompasses a long noncoding RNA, FLG-AS1 (Flg anti-sense). FLG-
AS1 has 9 isoforms. The overlap between the CNE 184 enhancer and exon 1 of FLG-AS1-005 
(ENST00000593011.5) suggests the existence of an enhancer RNA for this particular splice 
variant of FLG-AS. Recent studies have demonstrated that enhancer RNAs (eRNAs) contribute 
to regulating gene expression, that include stabilization of chromatin loops and targeting mRNAs 
for degradation (Kim et al. 2010). The interaction between the Flg promoter and the proximal 
region of the CNE 184 enhancer could indicate co-regulation of Flg and FLG-AS transcription 
during keratinocyte differentiation. The resulting FLG-AS transcript could likely participate in a 
positive feedback loop by stabilizing the chromatin interaction. 
As demonstrated in this chapter, chromatin conformation studies can help us elucidate 
mechanisms of gene activation by the discovery of putative regulatory elements. Often the 
regulatory elements that affect the expression of a gene expression might be distally located, 
making their target effects difficult to elucidate. Many common diseases cannot be completely 
explained by coding variants with an alternative hypothesis for regulatory variants for disease 
risks. Therefore, by identifying specific enhancer-promoter interactions and TADs within which 
genes and enhancers are likely to interact, chromatin conformation studies have the potential to 
pinpoint candidate regions for the identification of disease causing variants. 
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Figure 4.5. Distribution of CTCF binding sites across the EDC. ENCODE CTCF ChIP-seq reveals 
binding across a variety of cell lines that corresponds to the approximate boundaries of each of the EDC 
gene families. Binding intensities correspond to the darkness of the lines, and indicate varying intensities 
in different cell lines and tissues (UCSC Genome Browser build mm9). 
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4.5 Materials and Methods 
4.5.1  Circular chromosome conformation capture library preparation 
Primary keratinocytes were isolated from newborn mice as previously described 
(Lichti et al., 2008) and plated under proliferating or differentiating (2.0!mM Ca2+) conditions in 
custom keratinocyte media. The 4C assay was performed as previously described (Splinter et al., 
2012). Approximately 10 million cells were harvested at 72 hours post-calcium treatment and 
cross-linked while in single-cell suspension with 2% formaldehyde. The cross-linking reaction 
was quenched with 0.125M glycine followed by cell lysis to recover the nuclei. The cross-linked 
nuclei were incubated at 37ºC for 4 hours with 200U HindIII (New England BioLabs, Ipswich, 
MA). An additional 200U of HindIII was supplemented before the nuclei were incubated 
overnight, and again before another 4h incubation the following day. Each 4C library was 
assessed for efficient digestion by qPCR, using primers to amplify across a HindIII site and 
comparing the Ct values to amplification within a restriction fragment (primers listed in Table 
S1). The libraries were then ligated with T4 DNA ligase (New England BioLabs) overnight at 
16ºC. An aliquot from each library was electrophoresed on a 1.5% agarose gel and assessed for 
efficient ligation as determined by the presence of large molecular weight fragments. Libraries 
with satisfactory ligation efficiencies were then de-cross-linked using Proteinase K (IBI 
Scientific, Peosta, IA), and purified by phenol/chloroform (Life Technologies). A second 
digestion was performed at 37ºC overnight using 50U of NlaIII (New England BioLabs, Ipswich, 
MA). Again, each library was assessed for efficient digestion by qPCR (primers listed in Table 
S1) before proceeding to a second round of ligation. After efficient ligation was confirmed, 
libraries were purified using the QIAquick PCR purification kit (Qiagen). The 4C libraries were 
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amplified by inverse PCR followed by a nested PCR using primers containing Illumina adaptor 
tails to generate 4C amplicon libraries (Table S1). Both rounds of PCR used the Expand Long 
Template Polymerase (Roche) and the following PCR conditions: 94ºC for 2 min followed by 29 
cycles of 94ºC for 10 s, 55ºC for 1 min and 68ºC for 3min (Fig. S1). 4C amplicon libraries were 
sequenced using custom sequencing primers on an Illumina HiSeq 2500 (Illumina, Hayward, 
CA) (Fig. 4.1).  See Table S1 for inverse primer sequences and nested sequences. 
4.5.2  Data Analysis 
Mapping of 4C-seq reads 
The raw sequencing reads were first demultiplexed by allowing either 0, 1, or 2 mismatches in 
the index sequences. The successfully demultiplexed reads were then mapped to the mouse 
genome (UCSC mm10) using the Burrows-Wheeler Aligner (BWA). Using the Basic4Cseq 
software (Walter et al. 2014), the mapped reads were limited to a reduced genome containing 
only valid restriction fragments based on the restriction enzyme strategy used in the experiment 
and represent valid interactions. 
Determination of 4C-seq library quality 
Each 4C-seq library was assessed for quality using the Basic4Cseq software (Walter et al. 2014) 
prior to further analysis. The criteria for a good quality library was previously empirically 
determined as having at least 40% of cis-interactions and > 1 million reads (van de Werken et 
al., 2012) (Figure S6, Table S2).  
Identification of keratinocyte-specific 4C interactions 
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Libraries that passed the quality control criteria were used for the identification of keratinocyte-
specific interactions. Enrichment of interactions in keratinocytes versus P5424 T-cells was 
identified using the MACS peak caller (v1.4.2) (Zhang, et al., 2008). The default parameters 
were used for running MACS. For each bait, keratinocyte libraries (proliferating or 
differentiating) were used as “treatment” files, while T-cell libraries were used as “control” files. 
Identification of trans-interactions 
Peaks called by MACS were used as input for the Genomic Regulatory Enrichment of 
Annotations Tool (GREAT v3.0) (McLean, C., et al., 2010). The UCSC mm10 build was used, 
and GREAT hits that were significant by the binomial test (false discovery rate <0.05) were 
further considered. 
4.6 Supplementary Material  
Supplementary material may be viewed in Appendix C. 
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Chapter 5 
 
Conclusions  
5.1 Summary 
Early studies towards understanding transcriptional regulation initially focused on the 
proximal sequences for a gene of interest. For epidermal development, genetic approaches to 
elucidate the mechanisms underlying the keratinocyte-specific gene expression identified a 
shared core of p63, AP1, SP1, and C/EBP transcription factors in the activation of K5, K14, K1, 
K10, LOR, and IVL. These early studies approached gene regulation from a proximal and gene-
centric level. As seen in the regulation of EDC gene expression within the developing epidermis, 
proper control of gene expression is an intricate hierarchy of events. Due to the shared biology of 
the EDC genes, the EDC locus was eventually recognized as a gene cluster. The availability of 
whole genomes further identified sequence conservation of the EDC locus throughout 
mammalian evolution, and together with the conservation of expression patterns between 
mammalian species, indicated a selective pressure to maintain the locus as a regulatory module. 
Bioinformatics tools and high-throughput experimental techniques have subsequently allowed us 
to analyze the regulatory landscapes of the EDC locus as a whole.  
My work sought to identify the link between concomitant EDC gene expression pattern 
with respect to the 923 epidermal-specific enhancer during keratinocyte differentiation. Based on 
the assumption that sequence conservation in noncoding regions likely implies function 
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(Lindblad-Toh et al. 2011), 923 was identified as one of the 48 conserved non-coding elements 
within the EDC locus that could serve as potential modulators (enhancers or repressors) of the 
gene cluster (de Guzman Strong et al. 2010). This study demonstrated enhancer function for the 
human 923 sequence as it was sufficient to increase reporter gene expression in keratinocytes as 
well as direct epidermal specificity in transgenic reporter mice.  
In Chapter 2, I further demonstrated that the enhancer activity for 923 correlated with the 
dorsal to ventral patterning of skin barrier formation and the activation of marker genes of 
epidermal differentiation , K1, Lor, Flg, and Ivl (Oh et al. 2014). Using a tiling 3C assay to 
interrogate physical chromatin interactions between the 923 enhancer and EDC gene promoters, 
I discovered a 923-centric  chromatin architecture of the EDC that was dynamic with respect to 
keratinocyte differentiation. I further identified a requirement for AP-1 transcription factor 
binding to the 923 enhancer for EDC gene activation and chromatin remodeling based on 
bioinformatics and genetics studies that mapped the functional relevance of the AP-1 binding site 
and 3C assays on differentiated keratinocytes treated with the pharmacological AP-1 binding 
inhibitor Tanshinone IIA. As distal enhancers have been known to regulate gene expression via 
chromatin looping interactions (Ong and Corces 2011), my findings demonstrated this paradigm 
for keratinocyte biology as mediated by 923.  Furthermore, my identification of a role for AP-1 
to affect EDC gene expression and chromatin looping provided a link between studies that 
highlighted AP-1 as an important regulator of epidermal differentiation (Mehic et al. 2005; 
Rorke et al. 2010), with cell biology studies that identified remodeling of the EDC and proper 
nuclear spatial organization as requirements for EDC gene expression (Fessing et al. 2011; 
Mardaryev et al. 2013).  
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In Chapter 3, my goal was to determine if the 923 enhancer is necessary for EDC gene 
expression. I addressed the function of 923 by deleting the orthologous 923 sequence in mice 
using CRISPR/Cas9 genome editing. Targeted deletion of the 923 enhancer in vivo as a 
functional assay in mice is more feasible given the ease of design, cost, and specificity of the 
CRISPR/Cas9 genome editing technology. Using two designed sgRNAs to target Cas9 nuclease 
activity to the flanking ends of 923 and two loxP ssODNs with specific homology arms to enable 
the insertion of flanking loxP sequences by homology-directed repair, I recovered at least four 
923 mutation alleles.  They included one floxed 923 (923flox) with both loxP inserting in cis, two 
independent deletion alleles (923delA, 923delB), and one partial deletion with a remaining 238 bp 
of 923  (923pdel). Although  923delA and 923delB mice demonstrated normal viability and normal 
epidermal barrier structure and function, gene expression analysis of both deletion lines indicated 
an allele-dose dependent decrease in the expression of 923’s immediate neighbor, Ivl, and to a 
lesser extent, proximal genes Smcp and Lce6a, and distal genes Crnn and several of the Lce gene 
family members (Lce3a, Lce3b, Lce3e and Lce3f). Correlating with this observation was a 
compensatory upregulation of several members of the Sprr gene family (Sprr2a2, Sprr2e, 
Sprr2g, Sprr2i, Sprr2j, and Sprr1b) that are important to the integrity of the epidermal skin 
barrier as well. Thus, based on these initial studies, I identified a requirement for the 923 
enhancer for proximal and distal gene activation in the epidermis.  
In Chapter 4, I sought to identify the chromatin architecture of the EDC on a genome-wide 
scale with respect to the 923 enhancer and Flg promoter in keratinocytes compared to non-EDC 
expressing T cells. My previous approach towards understanding the chromatin interactions of 
923 using the 3C assays described in Chapter 2, provided a selective view on 923-mediated 
interactions that were limited to EDC promoter regions. With increasing evidence that chromatin 
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architecture is meditated by interactions between regulatory elements aside from enhance-
promoter interactions (Robyr et al. 2011), I was compelled to expand my view of 923-mediated 
chromatin architecture by using an unbiased 4C-seq approach. This would not only allow me to 
interrogate interactions across the EDC at a higher resolution, but also allow me to identify 
genome-wide interactions that would help me place the role of 923 and the EDC within a broader 
context of the many other genes involved in epidermal differentiation. I also included a second 
viewpoint at the Flg gene promoter in order to elucidate the underlying chromatin architecture 
that affects its expression. I was interested in Flg as it encodes a major structural protein of the 
skin barrier. As mentioned previously, FLG mutations in humans are associated with atopic 
dermatitis (AD), but only account for about 40% of the disease incidence (Palmer et al. 2006). 
However, the persistent linkage of AD to the EDC even after excluding known FLG mutations 
suggests that additional causal variants reside within the EDC that could include regulatory 
elements. The use of the Flg gene promoter as a viewpoint for a 4C-seq experiment would 
therefore allow me to identify candidate enhancers that could be modulators of Flg expression, 
while also providing an alternate view of the EDC chromatin landscape. From these experiments, 
both the 923 and Flg promoter viewpoints revealed a topology domain in the EDC that was 
specific to keratinocytes compared to T cells. Moreover, there also existed distinct chromatin 
interactions in keratinocytes, and even specifically in proliferative versus differentiated states. 
Interaction between the 923 enhancer and non-coding regions within the gene desert between the 
S100 and Sprr gene families were strongly enriched in keratinocytes and suggests the presence of 
as yet unannotated regulatory elements within the gene desert. Also, enhancer-enhancer 
chromatin interactions were observed in keratinocytes, suggesting a role for chromatin looping 
between enhancers to mediate keratinocyte-specific chromatin architecture of the EDC. These 
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studies emphasize the need to more closely examine these regions and their roles in shaping the 
EDC chromatin topology.  Furthermore, the interaction identified between the Flg promoter and 
enhancer 184 in the EDC demonstrate the potential of 4C-seq and other chromosome 
conformation capture techniques for pinpointing target regions for elucidating causal variants for 
diseases such as AD. 
Together, the results of my work establish a paradigm for enhancer-promoter chromatin 
interactions for gene activation specific to epidermal development. I characterized the AP-1-
dependent enhancer 923, demonstrating its role in mediating spatial interactions with numerous 
EDC gene promoters to establish a poised conformation for coordinating EDC gene activation 
upon the induction of epidermal differentiation (Oh et al. 2014). In Chapter 3, I further 
discovered that the loss of the 923 enhancer results in a dose-dependent decrease in proximal 
genes (Ivl, Smcp, and Lce6a) and distally located genes (Crnn and distal Lce family genes), along 
with an increased expression of Sprr genes, to maintain the integrity of the skin barrier. The 
exact nature of these mechanisms have yet to be explored. However, interactions between 923 
and other enhancer elements within the EDC (detailed in Chapter 4) suggest an intriguing model 
of chromatin looping mediated by enhancers in the Sprr, Lce, and Flg gene families to 
coordinate gene expression, and to rapidly activate functionally related genes as a “back-up” 
mechanism for overcoming the loss of functionally related proteins to maintain barrier integrity. 
These findings contributed to the field’s understanding of the regulatory landscapes, 
chromosome territories and topologically associated domains (TADs) that bring regulatory 
enhancers and promoters into close proximity for the purpose of transcriptional regulation in the 
context of keratinocyte differentiation. 
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5.2 Future Directions 
We have still much to learn about the regulatory principles that govern gene activation at 
the chromatin level and specifically in epidermal development. Elucidation of the molecular 
biology and biochemistry of enhancer-promoter interactions has opened up a new era to further 
investigate the paradigm of transcriptional regulation. Armed with new methodologies for 
genome sequencing and editing and protein engineering to both discover enhancers and to 
rapidly test their function, we approach a comprehensive understanding of the principles of 
genome architecture that modulate cellular transcriptomes at a faster rate than ever.   
Large amounts of genomics data have been generated due to the availability of whole 
genome sequences from increasing numbers of species (Lindblad-Toh et al. 2011), high-
throughput techniques such as ChIP-seq, RNA-seq, and DNase-seq. The accompanying 
development of bioinformatics tools to allow the integration of the genomic and epigenetic data 
(Hoffman et al. 2013), have made it possible to analyze gene regulation on a large-scale. These 
advances have enabled the field to identify enhancers across the genome based on correlative 
epigenetic marks. However, we are at a critical point in deciphering the function of these 
enhancers in skin biology and understanding the role that enhancers play in transcriptional 
regulation and genome organization.   
Previous evidence has shown that cohesin and CTCF play a role in maintaining enhancer-
promoter interactions in a multitude of cell-types and tissues (Hadjur et al. 2009; Mishiro et al. 
2009; Hou et al. 2010; Seitan et al. 2011). Specifically, CTCF has been shown to bind at the 
boundaries of TADs in a directional manner, creating insulator boundary elements that allow 
neighboring genes to be regulated in different ways (Dixon et al. 2012; Phillips-Cremins et al. 
 
 
108 
2013; Guo et al. 2015; Tang et al. 2015). My own results from the 4C-seq experiments described 
in Chapter 4 hint at the involvement of both 923 and Flg in a network of chromatin interactions 
involving genes and regulatory elements throughout the genome to act cooperatively in order to 
drive proper gene expression for epidermal differentiation. Within the EDC, the boundaries of 
the gene families correspond approximately with clusters of CTCF binding sites (UCSC mm10). 
Further, the discrete temporal activation of each EDC gene family during epidermal 
differentiation (de Guzman Strong et al. 2010) indicates independent regulation of each gene 
family. Taken together this suggests that CTCF is likely to be a major player in mediating the 
formation of chromatin loops by defining TADs within the EDC. An intriguing hypothesis to test 
is a functional role for CTCF to maintain normal EDC gene expression during epidermal 
development.  
Drawing from the expertise of the evolutionary biology field, we are now able to identify 
candidate regions with regulatory potential faster than ever (Siepel et al. 2005; Pennacchio et al. 
2006; Hemberg et al. 2012). Techniques such as the massively parallel reporter assay (MPRA) 
that allow high-throughput assessment of enhancer activity have also made the task of in vitro 
testing of multiple putative enhancers far less laborious (Kwasnieski et al. 2014). In Chapter 1, 
the loss of AP-1 binding to 923 significantly diminished, but did not entirely ablate the ability of 
923 to drive reporter gene expression or form chromatin interactions (Oh et al. 2014). This 
indicated a contribution of other unknown protein factors for 923’s enhancer activity. Our lab 
performed targeted sequencing of the 923 enhancer in a cohort of atopic dermatitis patients and 
identified atopic dermatitis (AD) patient-specific variants that are predicted to disrupt the binding 
of transcription factors with key roles in epidermal development, including Klf4 and Smad2:3:4 
(Quiggle, et al. unpublished data). These suggest targets for further dissection of the molecular 
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mechanisms governing 923’s enhancer activity. Additionally, the observed 4C-seq interactions 
between enhancers 923 and 531 in proliferating keratinocytes, as well as between the Flg 
promoter and enhancer 184 in differentiating keratinocytes, suggest that enhancers in the EDC 
are important for physiologically sensitive chromatin looping. The MPRA technique would 
allow us to perform mutation saturation of 923 and other enhancers of interest in order to gain a 
high-resolution view of how variants within these elements could modulate EDC gene 
expression and even in complex diseases such as AD.  
Advances in genome editing (CRISPR/Cas9, TALENs) available today have also made it 
easier than ever to functionally test the endogenous functions of enhancers (Fanucchi et al. 2013; 
Sander and Joung 2014; Lupiáñez et al. 2015).  They are also an advancement over transgenic in 
vivo studies that lack the ability to address the function of enhancers in the appropriate genomic 
context. The precision of these genome editing methods enables us to more directly test our 
hypotheses in specific locus/loci within the regulatory landscape. Our CRISPR/Cas9 generated 
923 knockout mice provide us with a unique opportunity to examine the importance and the 
necessity of 923 for mediating chromatin looping in the EDC by performing 3C or 4C assays on 
keratinocytes derived from the mice. By comparing the interactions observed in the homozygous 
mutants to wild-type littermates, we will be able to determine if the chromatin interactions 
observed previously using 923 as a bait are directly mediated by the 923 sequence, or if they 
were merely an artifact of a 923-independent chromatin architecture that brought 923 into 
proximity with the interacting regions. Furthermore, by overlaying the interaction data with 
RNA-seq data from these mice, we can draw conclusions about which interactions affect gene 
expression. We could also assess the allele-bias of 923 activity by using a heterozygous 
background to investigate the ability of the intact 923 to drive expression of the target genes on 
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the other allele harboring the deletion of 923. To test this, we would cross the 923 knockout 
mutants (C57BL/6xCBA) (backcrossed to select for the C57BL/6 background), to Balb/C mice 
and perform RNA-seq and 4C-seq on isolated epidermis from the heterozygous mice. The 
Balb/C line is one of the most phylogenetically distant strains from C57BL/6, for which over 
3,300 SNPs across the EDC locus have been identified between the strains, including 39 within 
EDC genes (Eppig et al. 2015). The informative SNPs will allow us to phase the haplotypes, thus 
identifying allele-specific interactions and transcription from the 4C-seq and RNA-seq, 
respectively. The proof-of-principle for this approach has been demonstrated in human cell-lines 
(Tang et al. 2015), and holds great potential for elucidating the role of chromatin architecture in 
human disease, an area still largely unexplored. 
The regulation of the Flg-like gene family is also as an interesting line of further 
investigation. As discussed earlier, human EDC enhancer 184 overlaps with an annotated splice 
variant of non-coding RNA, FLG-AS1-005 (Ensembl release 84) (Yates et al. 2016), as well as 
ENCODE annotated H3K27Ac active enhancer marks (Hoffman et al. 2013). Further, there is 
evidence that 184 forms chromatin interactions with a number of EDC genes which are 
aberrantly expressed in AD-patients (Quiggle, et al. unpublished data). This suggests the 
possibility that 184/FLG-AS1-005 is an eRNA that stabilizes the loop with Flg to drive 
expression. Future experiments such as RNA-ChIP can be employed to test the hypothesis that 
the FLG-AS1-005 transcript interacts with the chromatin loop involving 184 and Flg. 
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Appendix A 
Supplementary Material for Chapter 2 
 
Table S1. List of Mouse 3C Primers 
 
Forward primers 
923 (anchor) AGAAGGCAAGGGGAGGATAA 
2310050C09Rik GACACGGGTCCAACTACCTC 
Crct1 GTTGGTATAAGGGGCACAGG 
Crnn AGGACTCCTTCCTTCCCTCA 
Flg2 ATTAAAATAAGACCTGCTGGTAAACT 
Hrnr CCAGATGATCCAGACACCGTA 
Kprp CACCCCTCCTGCACATAAAT 
Lce1a1 TGATTTTTGTGTCCGTCTTCC 
Lce1a2 ATGTACCCAAATGCCCAGAG 
Lce1c GGACCCTGTCCTGAAATTCG 
Lce1d GAGACTCTGCTATCTACAGGTGACA 
Lce1e TAAGCCCTCTGACGAGCATC 
Lce1f TCATGATGAATTCTTTAACCTTTCT 
Lce3b CATGTCAATAGCTCTGTCATGTGT 
Lce3b_5’ CTGGGCATGGTCACTCCTAT 
Lor TGGAAGAGATTTAGGGAAGGAA 
Lor_5’ CCTCCCAGGAGACCCATTTA 
Pglyrp3 TTTTCTGAAGTACACCCTTTTGA 
Pglyrp4 AAGCAATTGGTTGCAGCTCT 
Rptn GACCACAGGGACTCAACGAT 
S100a1 GTGGGCTACGATCTCCTCTG 
S100a1_5' TGTGGTCTTTGCTGCTTTTG 
 
 
114 
S100a10 TTGTCTGGAGCTACCCCATC 
S100a13 CTCTTCACCTCCCGTTCAAA 
S100a14 GCAGGAAGATCTGGAAGTGC 
S100a16 CTGTGCTCTGCTCCGTGTT 
S100a2 CCAAGTTGTTAACATACCCAGCTA 
S100a4 GAGGCAGAGGCTGTCAGTTT 
S100a6 GGGCGTGTCAAGAAGGAGT 
S100a7a CAAAACAGTGCCTTGCTTCA 
S100a8 TGTATCATTTGGTGCTGGGTA 
S100a9 CACAGGTTGTTGGCTCTTTTT 
Sprr1a TCCTTTGACTCTGTCCCAAAA 
Sprr1b GGGGTGTGTACTCCGTGTTC 
Sprr2a1 CGTTCCCTTGCTATACTCCATC 
Sprr2b CAGGGGTGAACTACCAGGAG 
Sprr2e CACATGAACTAACTCAAGGTAGAGG 
Sprr2f CCTCAGTGTTCAGATCTGGGTAA 
Sprr3 AAGGGTGAAATCCAGGATGA 
Sprr4 CACACCTTTATGAAGAACCAGGA 
Tchh TGTTTTAATCTTTTCATAGAGACCACA 
Tchhl1_3’ TGGCCAATCTTGAACTCTGA 
 
Reverse primers 
923 (anchor) AATGGAAAGCACACCCAGAA 
Flg TGAGTTAGAAGTTGTGATCACTAGGAA 
Ivl GTCTGAGGTTCCTGCAATCC 
Lce1b GGAGGCATAAGCAGTCAGGA 
Lce6a TTGGGGATTGAGGAAAACAG 
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S100a11 GCCCAGTGCTAGGTTCAAA 
Sprr2d GAACCTAATGGCTCAGGCTCT 
Sprr2g AAGAATGGAATGAGGAATAGGAAAC 
Tchhl1 TTTTTCGGAAAGGTCACAACT 
 
Control primers 
cutF CACACCTTTATGAAGAACCAGGA 
cutR GGCTTCAGAAAACCTCCAGA 
uncutF GGGTTGCCATTCAATACCAC 
uncutR TCTGGGCTCCTCCTCTGTAA 
ERCC3-1 GCCCTCCCTGAAAATAAGGA 
ERCC3-2 GACTTCTCACCTGGGCCTACA 
 
 
Table S2. Mouse RT-PCR Primers 
 
Gene Forward Reverse 
2310050C09
Rik CCTGCCAGGAAAGAAGATTT ACAGTTTGAGGCTGGTAGGG 
Crct1 TTCTGCCTAGCAGGTGTCAA AGCAAGAGGAGGAGGAGGAC 
Crnn AACAGAAACTTGTCCCATCCTG TGACGTCAGCAAACTCATGTT 
Flg CTCCTTCAGCTGCATTCGAT TGCCTGTAGTTGTCCTTCCA 
Flg2 TGCGTCAGGCCTTATCCTAC TCCTTCTCCAGCAGTTCCTT 
Hrnr GCAAGCAACATCAGTCTCCA 
CAGAATTTGGTGAAACTCTGTTA
CC 
Ivl GCCTTCTCCCTCCTGTGAGT ATGTTTGGGAAAGCCCTTCT 
Kprp GCTCAGGTCCCAATCCAGTA CCTTGGTCTCCACAACCACT 
Lce1a1 CTCACCTTCCGAGGTATCCA AAGACACAGGGGGACACTTG 
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Lce1a2 GCCCAAGGATCTTGTACTGC CCAGGCTACAGCAGGAAGAC 
Lce1b TCCTCCTGAAGTGGCTACAGA CCAGGCTACAGCAGGAAGAC 
Lce1c ACTGGCTGAGAAACCCACAG CCAGGCTACAGCAGGAAGAC 
Lce1d ACTTCTCCTGAGGCGTCCAC CCAGGCTACAGCAGGAAGAC 
Lce1e CCACTCACTGGGTGAGATACC AACCCAAGCTACAGCAGGAA 
Lce1f ATCCACGCCATTAACACTGA CCAGGCTACAGCAGGAAGAC 
Lce3b AGCATCCTCAGACACGGACT TGTAGCACAGCAGGAAGAGG 
Lce3c TCTTCTCCTGCCTTTGCTGT TGCTGATTCCTCCAGACTGT 
Lce6a ATTTCTGGCCCCATAAAACC GCCTGCTGAACAAGAAGTCC 
Lor GGTCACCGGGTTGCAACGGA GAGACACTAGAATTGGGAGG 
Pglyrp3 TTGGCTTCTTGGCTCTCAGT CAATGTCACACCAGCCTTTG 
Pglyrp4 ATGCTGTCCTGGCTTCTTGT TCAGCTTAGAGCTGCAACCA 
Rptn CCTGCCTCTTCTGCTCATTC CCGAAGGATGTCTCCAAACT 
S100a1 CAGTGGCCACATTTGCAG TTCAGTTCTTTCTTGCTCAGCTT 
S100a10 CTGAGAGTGCTCATGGAACG TCCCCTTCTGCTTCATGTTT 
S100a11 CCACCGTCAGCCACAGTC ATCTAGCTGCCCGTCACAGT 
S100a13 CCTTGCCTGGTGCTTATAAACTT CCCTGCAAAGGTGAAGAAAG 
S100a14 GGCAGGCTATAGGACAGACG CCTCAGCTCCGAGTAACAGG 
S100a16a GAGGAGGTGGACTCACAGGA TCCAGGTTCTGGATGAGCTT 
S100a2 CGAGAGGCTCAAACACAACA GGGACCCCTCAAGGAAGTTA 
S100a4 CCCAAACCTCTCTATTCAGCA CTTTTCCCCAGGAAGCTAGG 
S100a6 ATCCCCTCGACCACTCCTT AGATCATCCATCAGCCTTGC 
S100a7a GGATAGTGTGCCTCGCTTCA AGACTGCCTGTCCTCCCTCT 
S100a8 CTGAGTGTCCTCAGTTTGTGC 
GACCTGAGATATGATGACTTTAT
TCTG 
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S100a9 GAAGGAAGGACACCCTGACA TCAACTTTGCCATCAGCATC 
Sprr1a 
GAGAACCTGCTCTTCTCTGAGTA
T GCAGGGCTCAGGAACAGG 
Sprr1b GCGACCACACTACCTGTCCT GGTGTCACAGGGTGTCTTGA 
Sprr2a1 TTCCTGGTACTCAAGCATTGG CAAGGCTCAAAGCACATGAC 
Sprr2b TTCCTGGTACTCAAGCATTGG CTTGGGTGGACACTTCTGCT 
Sprr2d CAAGGCCGAGACTACTTTGG ATGGCTCAGGACAAGGCTCT 
Sprr2e TCAGGTCCTAGGCTACTTTGG TATGAGGGAGGAGGACATGG 
Sprr2f CTGGTACACACGTCCTGGAA GCATTTCTGCTGGAATGAGG 
Sprr2g CAGGTCCTACACTACGTTGGAG CTGGCATGGAGAAGGAAGAC 
Sprr3 CCAAGAACCCAGTGATCTTCA TGTTTCCTGGTTGTGGAACA 
Sprr4 TCCCATCAGCATCAGAATCA TGCTGTGCAGGACACTTCTC 
Tchh TGATGGAGCATCACTTAGCAA GGCCTGATCGAGAGCATAAT 
Tchhl1 CACATTGCCCCACATTCC CCCTCAAGGAGCTGTCTCAG 
Krt1 
GACACCACAACCCGGACCCAAA
ACTTA 
ATACTGGGCCTTGACTTCCGAGA
TGATG 
Krt14 GGCCACCTACCTGGACAAG GTCGATCTGCAGGAGGACAT 
B2m TGGTGCTTGTCTCACTGACC CCGTTCTTCAGCATTTGGAT 
 
 
Table S3. RNA-seq results 
 
Gene Name log2(Diff/Prolif) P-Value FDR (False Discovery Rate) 
2310050C09Rik 5.96 2.81E-27 1.59E-25 
Crct1 4.77 1.15E-71 6.30E-69 
Crnn 3.58 2.63E-05 1.48E-04 
Flg 2.61 5.27E-05 2.77E-04 
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Flg2 8.65 8.08E-17 2.11E-15 
Hrnr 5.64 9.03E-19 2.81E-17 
Ivl 1.79 2.25E-10 2.95E-09 
Kprp 3.21 7.22E-21 2.77E-19 
Lce1a1 5.80 2.14E-27 1.23E-25 
Lce1a2 6.77 6.86E-24 3.16E-22 
Lce1b 5.24 2.34E-28 1.45E-26 
Lce1c 7.24 9.99E-40 1.17E-37 
Lce1d 6.09 1.64E-32 1.34E-30 
Lce1e 4.76 3.90E-23 1.73E-21 
Lce1f 6.89 1.42E-44 2.08E-42 
Lce3b 0.74 3.05E-01 4.44E-01 
Lce3c 2.58 2.49E-11 3.70E-10 
Lce6a 6.48 5.34E-14 1.06E-12 
Lor 6.25 1.70E-63 6.56E-61 
Pglyrp3 0.63 5.00E-03 1.52E-02 
Pglyrp4 3.93 5.18E-17 1.38E-15 
Rptn 3.67 1.31E-12 2.23E-11 
S100a1 1.05 6.87E-03 1.98E-02 
S100a10 0.92 2.14E-05 1.22E-04 
S100a11 1.40 7.85E-16 1.84E-14 
S100a13 0.94 7.09E-02 1.41E-01 
S100a14 1.82 2.15E-25 1.10E-23 
S100a16 1.75 2.20E-19 7.32E-18 
S100a2 -0.82 2.19E-01 3.47E-01 
S100a4 2.77 5.09E-11 7.25E-10 
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S100a6 1.67 4.93E-15 1.08E-13 
S100a7a 2.19 3.36E-12 5.48E-11 
S100a8 3.54 3.04E-18 9.03E-17 
S100a9 3.36 8.02E-36 7.89E-34 
Sprr1a 3.54 1.41E-26 7.69E-25 
Sprr1b 2.59 3.50E-28 2.15E-26 
Sprr2a1c 4.16 1.70E-04 7.95E-04 
Sprr2b 4.27 2.53E-25 1.28E-23 
Sprr2d 0.70 1.40E-02 3.66E-02 
Sprr2e -1.50 4.50E-05 2.41E-04 
Sprr2f 0.32 6.18E-01 7.46E-01 
Sprr2g 1.72 1.04E-09 1.26E-08 
Sprr3 1.12 3.27E-03 1.05E-02 
Sprr4 6.54 4.88E-18 1.42E-16 
Tchh 2.22 2.08E-18 6.27E-17 
Tchhl1 4.34 4.04E-16 9.77E-15 
 
Table S4. ChIP Primers 
 
Name Coordinates 
(NCBI37/mm
9) 
Forward Reverse 
Block 1 
 
(923 block 1) 
 
Chr3: 
92,380,676-
92380831 
CCTTGTGATGAATCCAA
GAAA 
TCTGGTCATATTCATCC
CTTCA 
Krt5 Chr15: AGACGTGTGTCTGCATC TTTGATGCGGTGAGCAA
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(ENCODE 
annotated site 
within keratin 5 
[Krt5]) 
 
101,540,819-
101,540975 
TGG TTA 
Neg 
 
(No ENCODE 
annotated site) 
Chr3: 
92,382,019-
92,382,161 
TGCTTGCTACTGGGTCT
CAA 
CCCTCCAAGTCCTATCA
TGC 
 
Supplemental Materials and Methods 
RNA-seq.  Total RNA was isolated by TriZol extraction (Life Technologies, Frederick, MD) 
from a parallel set of cells corresponding to cells used for the 3C libraries.  Poly-A mRNA was 
enriched (Dynabeads mRNA purification kit) and fragmented prior to SuperScript III 1st-strand 
synthesis system (Life Technologies, Frederick, MD) and subsequently the NEBNext mRNA 
Second Strand Synthesis Module (New England Biolabs, Ipswich, MA).  RNA-seq libraries were 
generated according to the manufacturer’s instructions (Illumina, Hayward, CA) and sequenced 
using the Illumina HiSeq 2000. 
A transcriptome index of the UCSC mm10 (GRCm38, Dec. 2011) mouse genome assembly was 
constructed using TopHat v2.0.5 (Trapnell et al. 2009).  Short, 50 bp single-end RNA-seq 
(Mortazavi et al. 2008) reads were aligned to the mouse genome with TopHat (parameter set: --
bowtie1 -a 5 -m 1 -i 10 -I 500000 -x 20 -n 2), allowing only one splice mismatch, two 
mismatches within a read, an average intron length of 500,000 bp, a minimum anchor length of 5 
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bp and a minimum exon length of 10 bp.  Reads that aligned to the transcriptome more than 20 
times were discarded.  Alignments were converted to SAM format using the samtools package 
(Li et al. 2009).  Aligned transcripts in the SAM file were counted using the htseq-count program 
(parameter set: --stranded=no –quiet).  Differential gene expression was calculated on the 
transcript counts using the Bioconductor edgeR package version 3.2.3 (Robinson et al. 2010).  
Significance cutoffs for differentially expressed genes were at FDR<0.001 and p<0.05. 
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Appendix B 
Supplementary Material for Chapter 3 
 
 Table S1.  Χ2 test for deviation from expected Mendelian ratio reveals normal viability of 923 
KO mice (α=0.05, df=2). 
923delA F2 
     Genotype Observed Ratio Expected Χ2 test 
Het 43 0.597222222 36 1.361111111 
 WT (-) 14 0.194444444 18 0.888888889 
 Mut (+) 15 0.208333333 18 0.5 
 
    
2.75 Χ2 statistic 
923delA F5 
     Genotype Observed Ratio Expected Χ2 test 
Het 71 0.489655172 72.5 0.031034483 
 WT (-) 32 0.220689655 36.25 0.498275862 
 Mut (+) 42 0.289655172 36.25 0.912068966 
 
    
1.44137931 Χ2 statistic 
923delB F2 
     Genotype Observed Ratio Expected Χ2 test 
 Het 84 0.482758621 87 0.103448276 
 WT (-) 42 0.24137931 43.5 0.051724138 
 Mut (+) 48 0.275862069 43.5 0.465517241 
 
    
0.620689655 Χ2 statistic 
923delB F4 
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Genotype Observed Ratio Expected Χ2 test 
 Het 79 0.512987013 77 0.051948052 
 WT (-) 28 0.181818182 38.5 2.863636364 
 Mut (+) 47 0.305194805 38.5 1.876623377 
 
    
4.792207792 Χ2 statistic 
923pdel F6 
  Genotype Observed Ratio Expected Χ2 test 
Het 8 0.216216216 18.5 5.959459459 
 WT (-) 11 0.297297297 9.25 0.331081081 
 Mut (+) 18 0.486486486 9.25 8.277027027 
 
    
14.56756757 Χ2 statistic 
Small Guide RNA (sgRNA) targeting sequences 
Upstream 5’ sgRNA 
5’- GAATACATCCCAGGAACAT -3’ 
Downstream 3’ sgRNA 
5’- CAGTAAGCTAGCGCTAGAC -3’ 
 
ssODN sequences 
Upstream 5’ ssODN 
5’-
AGAAGTTTTTCAGTTCCCCATAGTTGTCCTGAGGAGCATATAATCTTTGTCTTAAGCAGATTTG
TTTACAATAATTCCCTATAACTTCGTATAGCATACATTATACGAAGTTATGCATGCTTTAAAGA
GATAGAGGACTGACATGACCCTCTGTCCTCTAAAACAAGTTTGCCAGGATTTCTCCATTCCCAG
AGCCATGA-3’ 
Downstream 3’ ssODN 
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5’-
TCTCTGTTGTTAGAGTCCATCTCCTACACCGATAGAGACTGATTCTGAAAAAAAAGGAAGCTCC
CACTGTCCAAGTTCTAAAGCTTATAACTTCGTATAGCATACATTATACGAAGTTATTGGAAACC
AGACACCCTGGCTGCTGCTCTGAAGGCAACTCTTCCCTATCAGGCTCCTTAATAGGATTTGATC
AGTGTGAC-3’ 
SphI restriction site 
HindIII restriction site 
Homology arms 
LoxP site 
 
Genotyping primers 
Mutant line F primer R primer 
Mutant 
allele 
Wildtype 
allele 
923delA 
CAGTTCCCCATAGTTGTCCTG GGAAGAGTTGCCTTCAGAGC 
317 
1407 923delB 164 
923pdel 579 
923fl 
5' loxP 
TCTTTAGTGCTCAGTTAACAGC
T 
AGTCCTCTATCTCTTTAAAGCAT
GCATAAC 259 - 
3' loxP 
GTTCTAAAGCTTATAACTTCGT
ATAGCA TGCCTCACCAAATTCTCACA 195 - 
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qPCR primers 
Gene Forward Reverse 
Crnn  AACAGAAACTTGTCCCATCCT
G 
TGACGTCAGCAAACTCATGTT 
Flg CTCCTTCAGCTGCATTCGAT TGCCTGTAGTTGTCCTTCCA 
Flg2 TGCGTCAGGCCTTATCCTAC TCCTTCTCCAGCAGTTCCTT 
Hrnr GCAAGCAACATCAGTCTCCA CAGAATTTGGTGAAACTCTGTTACC 
Ivl GCCTTCTCCCTCCTGTGAGT ATGTTTGGGAAAGCCCTTCT 
Lor  GGTCACCGGGTTGCAACGGA GAGACACTAGAATTGGGAGG 
Rptn  CCTGCCTCTTCTGCTCATTC CCGAAGGATGTCTCCAAACT 
Sprr2d  CAAGGCCGAGACTACTTTGG ATGGCTCAGGACAAGGCTCT 
Sprr3  CCAAGAACCCAGTGATCTTCA TGTTTCCTGGTTGTGGAACA 
Evpl TCAAGGGGCTGAGCAAAG AGCTTCTTCTGCGTCTCCAA 
Ppl ATACAGCCCAACGGTGCAG CAGCACGTACAGCAGCTTTT 
B2m  TGGTGCTTGTCTCACTGACC CCGTTCTTCAGCATTTGGAT 
 
 
RNA-seq results: Differential Expression relative to wildtype 
Gene logFC het logFC mut 
adj.P.Val 
het 
adj.P.Val 
mut 
S100a1 2.01E-01 5.78E-01 9.66E-01 9.84E-01 
S100a13 5.79E-01 -6.02E-02 9.66E-01 9.84E-01 
S100a14 1.26E-01 -8.39E-02 9.66E-01 9.84E-01 
S100a16 -7.12E-02 4.08E-02 9.66E-01 9.84E-01 
S100a2 -1.31E+00 -2.26E+00 9.66E-01 7.67E-01 
S100a3 2.01E+00 -1.14E-02 1.60E-01 9.92E-01 
S100a4 5.92E-01 1.76E-02 9.66E-01 9.89E-01 
S100a5 1.09E-01 -6.38E-02 9.66E-01 9.84E-01 
S100a6 5.35E-01 -5.49E-02 9.66E-01 9.84E-01 
S100a7a 1.49E+00 7.49E-01 9.66E-01 9.84E-01 
S100a8 1.52E+00 4.86E-01 9.66E-01 9.84E-01 
S100a9 4.16E-01 1.05E+00 9.66E-01 9.84E-01 
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Pglyrp4 -2.24E-01 3.47E-01 9.66E-01 9.84E-01 
Pglyrp3 7.35E-02 2.41E-01 9.66E-01 9.84E-01 
Lor -2.42E-01 -2.75E-02 9.66E-01 9.84E-01 
Prr9 6.85E-01 -8.96E-01 9.66E-01 9.84E-01 
Lelp1 6.74E-01 -7.17E-01 9.66E-01 9.84E-01 
Sprr2a1 1.09E-01 -6.38E-02 9.66E-01 9.84E-01 
Sprr2a1 1.09E-01 -6.38E-02 9.66E-01 9.84E-01 
Sprr2a2 1.09E-01 8.27E-01 9.66E-01 8.44E-01 
Sprr2a2 1.09E-01 8.27E-01 9.66E-01 8.44E-01 
Sprr2a3 -6.55E-01 3.02E-01 9.66E-01 9.84E-01 
Sprr2b -7.32E-01 1.43E+00 9.66E-01 9.10E-01 
Sprr2d -7.78E-01 1.17E+00 9.66E-01 7.17E-01 
Sprr2e -2.66E-01 1.21E+00 9.66E-01 9.84E-01 
Sprr2f -1.39E+00 -1.55E-02 9.66E-01 9.95E-01 
Sprr2g 1.24E-01 1.71E+00 9.68E-01 9.84E-01 
Sprr2h -5.80E-01 1.57E-01 9.66E-01 9.84E-01 
Sprr2i 2.64E-01 1.20E+00 9.66E-01 9.84E-01 
Sprr2j-ps -1.09E-01 1.03E+00 9.66E-01 9.84E-01 
Sprr2k -5.84E-01 1.81E-01 9.66E-01 9.84E-01 
Sprr1b -5.04E-01 1.06E+00 9.66E-01 9.84E-01 
Sprr3 -3.22E+00 -1.23E+00 9.04E-01 9.84E-01 
Sprr1a -1.53E-01 4.58E-01 9.66E-01 9.84E-01 
Sprr4 9.98E-01 6.94E-01 9.66E-01 9.84E-01 
Ivl -8.40E-01 -4.93E+00 5.75E-01 4.58E-04 
Smcp -9.23E-01 -2.95E+00 9.66E-01 2.80E-01 
Lce6a -3.07E-01 -1.71E+00 9.66E-01 9.84E-01 
Lce1a1 -2.33E-01 -8.65E-02 9.66E-01 9.84E-01 
Lce1b -6.27E-02 -9.21E-03 9.66E-01 9.90E-01 
Lce1a2 -1.15E-01 4.03E-02 9.66E-01 9.84E-01 
Lce1c -1.70E-01 -4.23E-02 9.66E-01 9.84E-01 
Lce1e -2.34E-01 8.44E-02 9.66E-01 9.84E-01 
Lce1f -4.11E-01 3.62E-02 9.66E-01 9.84E-01 
Lce1g -1.88E-01 1.98E-01 9.66E-01 9.84E-01 
Lce1h -8.97E-02 4.04E-01 9.66E-01 9.84E-01 
Lce1i -8.13E-03 2.59E-01 9.94E-01 9.84E-01 
Lce1j -3.16E-02 6.84E-01 9.82E-01 9.84E-01 
Lce1k 1.59E-01 3.93E-01 9.66E-01 9.84E-01 
Kprp -6.75E-01 -1.56E-01 6.63E-01 9.84E-01 
Lce1l -1.59E-01 4.21E-01 9.66E-01 9.84E-01 
Lce3a -2.08E+00 -1.59E+00 9.66E-01 9.84E-01 
Lce3b -2.33E+00 -5.95E-01 8.92E-01 9.84E-01 
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Lce3c -4.84E-01 -9.96E-02 9.66E-01 9.84E-01 
Lce3d -5.77E-01 5.65E-01 9.66E-01 9.84E-01 
Lce3e -8.12E-01 -1.51E+00 9.66E-01 6.78E-01 
Lce3f -2.19E+00 -2.48E+00 9.66E-01 9.84E-01 
Crct1 5.15E-02 -4.66E-02 9.66E-01 9.84E-01 
Lce1m 3.96E-02 -1.16E-01 9.67E-01 9.84E-01 
Crnn -6.76E-01 -1.73E+00 8.45E-01 3.07E-02 
Flg2 3.03E-01 4.76E-01 9.66E-01 9.11E-01 
Hrnr -8.69E-02 1.45E-01 9.66E-01 9.84E-01 
Rptn -3.00E-01 1.35E+00 9.66E-01 9.84E-01 
Tchh 2.66E-01 -9.53E-02 9.66E-01 9.84E-01 
Tchhl1 8.49E-01 -4.92E-01 9.66E-01 9.84E-01 
S100a11 -2.21E-01 -3.22E-01 9.66E-01 9.84E-01 
S100a10 -6.16E-02 -1.47E-01 9.66E-01 9.84E-01 
     Evpl -1.48E+00 -1.33E-01 -4.90E-02 9.84E-01 
Ppl 2.66E-01 -9.53E-02 1.16E-01 9.84E-01 
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Appendix C 
Supplementary Material for Chapter 4 
 
Table S1. Custom Primers for 4C-seq 
Nested$Inverse$PCR$
Guide$Primers$
$Name$
$923$Read$HindIII$ AATGATACGGCGACCACCGAGATCTGTCAGATCTCAACATTCCTGTCAAA 923$Index$1$NlaIII$ CAAGCAGAAGACGGCATACGAGATAACCTCAACAACTTCCTAATATTTTAATGTCAAACAA 923$Index$2$NlaIII$ CAAGCAGAAGACGGCATACGAGATTCTAAGCACAACTTCCTAATATTTTAATGTCAAACAA 923$Index$3$NlaIII$ CAAGCAGAAGACGGCATACGAGATCTGTCATACAACTTCCTAATATTTTAATGTCAAACAA 923$Index$4$NlaIII$ CAAGCAGAAGACGGCATACGAGATGGAGGTGACAACTTCCTAATATTTTAATGTCAAACAA 923$Index$5$NlaIII$ CAAGCAGAAGACGGCATACGAGATGCTCGATACAACTTCCTAATATTTTAATGTCAAACAA 923$Index$6$NlaIII$ CAAGCAGAAGACGGCATACGAGATTAGAGTAACAACTTCCTAATATTTTAATGTCAAACAA 923$Index$7$NlaIII$ CAAGCAGAAGACGGCATACGAGATTCAGTCTACAACTTCCTAATATTTTAATGTCAAACAA 923$Index$8$NlaIII$ CAAGCAGAAGACGGCATACGAGATTTCCAAGACAACTTCCTAATATTTTAATGTCAAACAA 923$Index$9$NlaIII$ CAAGCAGAAGACGGCATACGAGATTAATCGGACAACTTCCTAATATTTTAATGTCAAACAA Flg$Read$HindIII$ AATGATACGGCGACCACCGAGATCTTGAGTTAGAAGTTGTGATCACTAGGAA Flg$Index$10$NlaIII$ CAAGCAGAAGACGGCATACGAGATCGCTGCCAAATTGGAAGCTACAAAAACATAGGTA Flg$Index$11$NlaIII$ CAAGCAGAAGACGGCATACGAGATATGATGGAAATTGGAAGCTACAAAAACATAGGTA Flg$Index$12$NlaIII$ CAAGCAGAAGACGGCATACGAGATCTTGTTAAAATTGGAAGCTACAAAAACATAGGTA Flg$Index$13$NlaIII$ CAAGCAGAAGACGGCATACGAGATACGCCTCAAATTGGAAGCTACAAAAACATAGGTA Flg$Index$14$NlaIII$ CAAGCAGAAGACGGCATACGAGATAGTTAAAAAATTGGAAGCTACAAAAACATAGGTA Flg$Index$15$NlaIII$ CAAGCAGAAGACGGCATACGAGATGAGGACCAAATTGGAAGCTACAAAAACATAGGTA Flg$Index$16$NlaIII$ CAAGCAGAAGACGGCATACGAGATGCCACCGAAATTGGAAGCTACAAAAACATAGGTA Flg$Index$17$NlaIII$ CAAGCAGAAGACGGCATACGAGATCGACAGTAAATTGGAAGCTACAAAAACATAGGTA 
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Flg$Index$18$NlaIII$ CAAGCAGAAGACGGCATACGAGATCAAATACAAATTGGAAGCTACAAAAACATAGGTA Eβ$Read$HindIII$ AATGATACGGCGACCACCGAGATCTAGTGGTAGGAATTGTTAGGAAAAGAAG Eβ$Index$19$NlaIII$ CAAGCAGAAGACGGCATACGAGATCGTACTCATTTCAGCTCTCATCTATGAATGTAAGAGT Eβ$Index$20$NlaIII$ CAAGCAGAAGACGGCATACGAGATTATCTGTATTTCAGCTCTCATCTATGAATGTAAGAGT Eβ$Index$21$NlaIII$ CAAGCAGAAGACGGCATACGAGATCATTGAGATTTCAGCTCTCATCTATGAATGTAAGAGT 
$ $Sequencing)Primers)
$Name$
$923$Read$ GTCAGATCTCAACATTCCTGTCAAAGCTT 923$Index$Read$ TTGTTTGACATTAAAATATTAGGAAGTTGT Flg$Read$ AGAAGTTGTGATCACTAGGAATACAAGCTT Flg$Index$Read$ TACCTATGTTTTTGTAGCTTCCAATTT Eβ$Read$ AGTGGTAGGAATTGTTAGGAAAAGAAGCTT Eβ$Index$Read$ ACTCTTACATTCATAGATGAGAGCTGAAAT 
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Figure S1.  4C-seq nested PCR products. The nested products were separated on a 1.5% 
agarose gel. The leftmost lane contains a 1 Kb Plus DNA Ladder (Invitrogen). The smears and 
discrete bands indicate that the 4C library contains amplicons of various sizes and quantities, 
representing a variety of interacting sequences and interaction frequencies. PCR products larger 
than ~120bp were cut out and submitted for sequencing to exclude primer dimers.  
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Figure S2. Demultiplexing distribution allowing for 1 or 0 mismatches in the index. 
Allowing for 1 mismatch in the index sequences resulted in a range of 47,000 reads – 6.2 million 
reads per library in lane 6, and 43,000 reads – 6.9 million reads per library in lane 7. When 
mismatches were not allowed, only 5315 reads - 4.4 million reads were obtained per library in 
lane 6, 6535 reads - 4.8 million reads per library in lane 7. Approximately 60 million reads were 
unassignable even allowing for 1 mismatch, while approximately 80 million reads were 
unassigned when no mismatches were allowed.  
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Figure S3. View of the EDC in Flg 4C-seq libraries demultiplexed by allowing 1 mismatch (left) and 0 mismatches (right) in 
index sequences. Different colored tracks indicate different cell types or conditions (green: differentiated keratinocytes, blue: 
proliferating keratinocytes, black: P5424 T-cells).  A viewpoint-like peak is observed at 923 in one of the P5424 Flg libraries 
generated by allowing 1 mismatch in the index. This peak is not present in the same library generated by allowing 0 mismatch in the 
index, indicating that contamination between libraries was a result of mismatches allowed during demultiplexing. 
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Figure S4. View of the EDC in 923 4C-seq libraries demultiplexed by allowing 0 
mismatches in index sequences. Different colored tracks indicate different cell types or 
conditions (green: differentiated keratinocytes, blue: proliferating keratinocytes, black: P5424 T-
cells). 
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Figure S5. View of the EDC in Eβ 4C-seq libraries demultiplexed by allowing 0 mismatches 
(bottom) in index sequences. Different colored tracks indicate different cell types or conditions 
(green: differentiated keratinocytes, blue: proliferating keratinocytes, black: P5424 T-cells). 
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Figure S6. 4C-seq library quality. Libraries were assessed based on the criteria of having at 
least 1 million total reads mapping to fragments (blue), between 300,000 – 1 million reads 
(grey), or less that 300,000 reads (black), and the number of reads mapping in cis and near the 
viewpoint/bait. Good quality libraries have over 1 million reads (blue), over 40% of reads 
mapping in cis, and over 40% of the fragments near the viewpoint having reads mapping to them 
(upper right quadrant). 
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Table S2. 4C-seq library quality.  
Lane 6 Library quality Lane 7 Library quality 
Good Poor Good Poor 
923 D1 923 D2 923 D1 923 D2 
923 P5424 2 923 D3 923 P5424 2 923 D3 
923 P5424 3 923 P1 923 P5424 3 923 P1 
Eβ P5424 1 923 P2 Eβ P5424 1 923 P2 
Eβ P5424 2 923 P3 Eβ P5424 2 923 P3 
Eβ P5424 3 923 P5424 1 Eβ P5424 3 923 P5424 1 
Flg D3 Flg D1 Flg D3 Flg D1 
Flg P5424 1 Flg D2 Flg P5424 1 Flg D2 
Flg P5424 3 Flg P1 Flg P5424 3 Flg P1 
 
Flg P2 
 
Flg P2 
 
Flg P3 
 
Flg P3 
 
Flg P5424 2 
 
Flg P5424 2 
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Table S3. GREAT-predicted cis-regulatory targets of 4C-seq reads enriched in 923 enhancer viewpoint differentiating 
keratinocytes (923 KerD) relative to T-cells. 
ID# Desc# BinomFdrQ# Genes#
GO:0031424) keratinization) 2.60E614) Ivl,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2i,Sprr3,Sprr4#
GO:0001533) cornified)envelope) 2.67E614) Ivl,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2i#
GO:0030216) keratinocyte)differentiation) 3.35E605) Ivl,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2i,Sprr3,Sprr4,Yap1#
GO:0042834) peptidoglycan)binding) 2.14E603) Pglyrp3,Tlr2)
GO:0016019) peptidoglycan)receptor)activity) 4.07E603) Pglyrp3#
GO:0008745) N6acetylmuramoyl6L6alanine)amidase)activity) 4.07E603) Pglyrp3#
GO:0016045) detection)of)bacterium) 4.16E603) Naip6,Pglyrp3,Tlr2)
GO:0006027) glycosaminoglycan)catabolic)process) 4.93E603) Hyal4,Pglyrp3)
GO:0009253) peptidoglycan)catabolic)process) 5.26E603) Pglyrp3#
GO:0044117) growth)of)symbiont)in)host) 5.87E603) Pglyrp3#
GO:0032827)
negative)regulation)of)natural)killer)cell)differentiation)
involved)in)immune)response) 5.87E603) Pglyrp3#
GO:0009595) detection)of)biotic)stimulus) 2.93E602) Naip6,Pglyrp3,Tlr2,Tlr4)
GO:0006026) aminoglycan)catabolic)process) 3.25E602) Hyal4,Pglyrp3)
GO:0008329) signaling)pattern)recognition)receptor)activity) 3.30E602) Pglyrp3,Tlr2,Tlr4)
 
Table S4. GREAT-predicted cis-regulatory targets of 4C-seq reads enriched in 923 enhancer viewpoint proliferating 
keratinocytes (923 KerP) relative to T-cells. 
 
 
 
ID# Desc# BinomFdrQ# Genes#
GO:0016503) pheromone)receptor)activity) 1.35E603)
Gm4133,Gm4187,V1ra8,Vmn1r119,Vmn1r13,Vmn1r14,Vmn1r15,Vmn1r16,Vmn1r165,Vmn1r17,Vmn1r1
8,Vmn1r185,Vmn1r2,Vmn1r234,Vmn1r235,Vmn1r238,Vmn1r26,Vmn1r27,Vmn1r29,Vmn1r3,Vmn1r30,V
mn1r39,Vmn1r41,Vmn1r42,Vmn1r53,Vmn1r57,Vmn1r71,Vmn1r77,Vmn1r78,Vmn1r88,Vmn1r89)
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Table S5. GREAT-predicted cis-regulatory targets of 4C-seq reads enriched in Flg promoter viewpoint differentiating 
keratinocytes (Flg KerD) relative to T-cells. 
ID# Desc# BinomFdrQ# Genes#
GO:0001533) cornified)envelope) 4.89E618) Anxa1,Flg,Hrnr,Ivl,Lor,Rptn,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i#
GO:0016019)
peptidoglycan)receptor)
activity) 2.87E614) Pglyrp3,Pglyrp4#
GO:0008745)
N6acetylmuramoyl6L6alanine)
amidase)activity) 2.87E614) Pglyrp3,Pglyrp4#
GO:0044117) growth)of)symbiont)in)host) 8.29E614) Pglyrp3,Pglyrp4#
GO:0032827)
negative)regulation)of)
natural)killer)cell)
differentiation)involved)in)
immune)response) 8.29E614) Pglyrp3,Pglyrp4#
GO:0009253)
peptidoglycan)catabolic)
process) 9.35E614) Pglyrp3,Pglyrp4#
GO:0031424) keratinization) 3.83E613) Abca12,Hrnr,Ivl,Lor,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Sprr4)
GO:0042834) peptidoglycan)binding) 4.20E613) Pglyrp3,Pglyrp4#
GO:0006026)
aminoglycan)catabolic)
process) 1.90E612) BC051070,Chi3l3,Chi3l4,Chi3l7,Chia,Pglyrp3,Pglyrp4)
GO:0006027)
glycosaminoglycan)catabolic)
process) 2.28E611) Pglyrp3,Pglyrp4#
GO:0016045) detection)of)bacterium) 6.80E610) Pglyrp3,Pglyrp4#
GO:0032823)
regulation)of)natural)killer)
cell)differentiation) 1.83E608) Pglyrp3,Pglyrp4#
GO:0008329)
signaling)pattern)recognition)
receptor)activity) 4.90E608) Colec12,Pglyrp3,Pglyrp4)
GO:0032689)
negative)regulation)of)
interferon6gamma)
production) 4.72E606) Gata3,Pglyrp3,Pglyrp4)
GO:0032814)
regulation)of)natural)killer)
cell)activation) 5.76E606) Il12b,Lyst,Pglyrp3,Pglyrp4)
GO:0009595) detection)of)biotic)stimulus) 8.61E606) Pglyrp3,Pglyrp4#
GO:0016811)
hydrolase)activity,)acting)on)
carbon6nitrogen)(but)not)
peptide))bonds,)in)linear)
amides) 1.48E605) Acer2,Acy1,Aga,Gls,Hdac2,Hdac9,Ngly1,Pglyrp3,Pglyrp4)
GO:0030216) keratinocyte)differentiation)) 2.29E605)
Abca12,Anxa1,Ctnnd1,Hrnr,Ivl,Lor,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Sprr4,Trp6
3)
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GO:0002698)
negative)regulation)of)
immune)effector)process) 1.64E604) Bcl6,Irak3,Itch,Pglyrp3,Pglyrp4,Tgfb2)
GO:0045620)
negative)regulation)of)
lymphocyte)differentiation) 3.37E604) Bcl6,Gli3,Pglyrp3,Pglyrp4)
GO:0009913)
epidermal)cell)
differentiation) 2.45E603)
Abca12,Anxa1,Atoh1,Clic5,Clrn1,Ctnnd1,Ercc3,Gli2,Grxcr1,Hdac2,Hrnr,Ivl,Lor,Myo7a,Pcdh15,Slitrk6,Sprr1b,Sprr2a
1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Sprr4,Trp63)
GO:0001818)
negative)regulation)of)
cytokine)production) 3.41E603) Bcl6,Chrna7,Gata3,Gata6,Ido1,Ifng,Il12b,Il6ra,Irak3,Irg1,Pglyrp3,Pglyrp4,Tgfb2,Trim27,Vsig4)
GO:0050866)
negative)regulation)of)cell)
activation) 3.91E603) Bcl6,Cnr1,Gli3,Ido1,Itch,Pawr,Pde5a,Pdgfa,Pdgfb,Pglyrp3,Pglyrp4,Prdm1,Serpine2,Socs6,Sox11,Vsig4,Vtcn1)
GO:0016810)
hydrolase)activity,)acting)on)
carbon6nitrogen)(but)not)
peptide))bonds) 3.93E603) Acer2,Acy1,Adar,Aga,Apobec4,Atic,Gls,Hdac2,Hdac9,Ngly1,Pglyrp3,Pglyrp4)
GO:0050830)
defense)response)to)Gram6
positive)bacterium) 4.46E603) Il6ra,Pglyrp3,Pglyrp4)
GO:0071229) cellular)response)to)acid) 5.37E603) Col1a1,Col1a2,Col4a6,Ipo5,Pdgfc,Pdgfd,S100a10,Sh3bp4)
GO:0005391)
sodium:potassium6
exchanging)ATPase)activity) 5.39E603) Atp1a1,Atp1a2,Atp1a4,Atp1b1)
GO:0051250)
negative)regulation)of)
lymphocyte)activation) 6.60E603) Bcl6,Gli3,Ido1,Itch,Pawr,Pde5a,Pglyrp3,Pglyrp4,Prdm1,Socs6,Sox11,Vsig4,Vtcn1)
GO:0008556)
potassium6transporting)
ATPase)activity) 1.17E602) Atp1a1,Atp1a2,Atp1a4,Atp1b1)
GO:0008544) epidermis)development) 1.68E602)
Abca12,Anxa1,Atoh1,Barx2,Clic5,Clrn1,Ctnnd1,Ercc3,Flg,Foxq1,Gli2,Grxcr1,Hdac2,Hrnr,Igf1r,Inhba,Ivl,Lce1g,Lce1i,
Lce1l,Lce1m,Lce3a,Lce3c,Lce3f,Lor,Myo7a,Pcdh15,Pdgfa,Pou3f2,Slitrk6,Sprr1b,Sprr2a1,Sprr2a2,Sprr2a3,Sprr2f,S
prr2g,Sprr2h,Sprr2i,Sprr3,Sprr4,Tgfb2,Trp63)
GO:0002695)
negative)regulation)of)
leukocyte)activation) 1.73E602) Bcl6,Cnr1,Gli3,Ido1,Itch,Pawr,Pde5a,Pglyrp3,Pglyrp4,Prdm1,Socs6,Sox11,Vsig4,Vtcn1)
GO:0009408) response)to)heat) 2.12E602) Casq1,Cetn1,Crnn,Psip1,Xylt1)
GO:0043588) skin)development) 2.18E602)
Abca12,Anxa1,Arrdc3,Atoh1,Barx2,Clic5,Clrn1,Col1a1,Col1a2,Ctnnd1,Ercc3,Flg,Foxq1,Gli2,Grxcr1,Hdac2,Hrnr,Igf1r
,Inhba,Ivl,Lce1g,Lce1i,Lce1l,Lce1m,Lce3a,Lce3c,Lce3f,Lor,Myo7a,Pcdh15,Pdgfa,Pou3f2,Slitrk5,Slitrk6,Sprr1b,Sprr2
a1,Sprr2a2,Sprr2a3,Sprr2f,Sprr2g,Sprr2h,Sprr2i,Sprr3,Sprr4,Tcf7l2,Tgfb2,Trp63)
GO:0004013)
adenosylhomocysteinase)
activity) 2.29E602) Ahcy,Ahcyl1,Gm4737)
GO:0005509) calcium)ion)binding) 3.77E602)
9130204L05Rik,Adam8,Amy2a5,Anxa1,Bglap,Calb1,Casq1,Cdh10,Cdh12,Cdh18,Cdh19,Cdh2,Cdh20,Cdh6,Cdh7,Cd
h9,Cetn1,Clstn3,Crnn,Dmd,Dnahc7b,Dsc3,Edem1,Edil3,Efemp1,Egfem1,Egfl6,Eltd1,Epdr1,Fat4,Fbln5,Fbn2,Flg,Flg2
,Fscb,Fstl5,Gm5849,Gpd2,Grm7,Hrnr,Kcnip4,Lrp1b,Man1a,Man1a2,Mctp2,Notch2,Pcdh10,Pcdh15,Pcdh17,Pcdh18
,Pcdh19,Pcdh20,Pcdhb22,Pclo,Plcl2,Pls3,Rptn,S100a10,S100a11,S100a3,Slc25a13,Slc25a24,Slit2,Sulf1,Syt1,Tchhl1
,Wdr49)
GO:0030280)
structural)constituent)of)
epidermis) 3.82E602) Lor#
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GO:0016160) amylase)activity) 3.97E602) Amy2a5,Mgam)
 
Table S6. GREAT-predicted cis-regulatory targets of 4C-seq reads enriched in Flg promoter viewpoint proliferating 
keratinocytes (Flg KerP) relative to T-cells. 
ID) Desc) BinomFdrQ) Genes)
GO:0009593)
detection)of)chemical)
stimulus) 6.73E604)
Gm10081,Gnat3,Kcnmb2,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr1257,Olfr13,Olfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
974,Rtp4,Tlr2,Tlr4,Trpa1)
GO:0050906)
detection)of)stimulus)
involved)in)sensory)
perception) 9.36E604)
Col11a1,Gm10081,Gnat3,Gpr98,Myc,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr1257,Olfr13,Olfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
974,Pcdh15,Rtp4,Sox2,Trpa1)
GO:0051606) detection)of)stimulus) 1.57E603)
Cadm1,Cngb3,Col11a1,Gm10081,Gnat3,Gpr98,Kcnmb2,Myc,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr125
7,Olfr13,Olfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
974,Pcdh15,Rtp4,Sox2,Tlr2,Tlr4,Trpa1)
GO:0050907)
detection)of)chemical)
stimulus)involved)in)sensory)
perception) 2.09E603)
Gm10081,Gnat3,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr1257,Olfr13,Olfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
974,Rtp4,Trpa1)
GO:0050911)
detection)of)chemical)
stimulus)involved)in)sensory)
perception)of)smell) 2.32E603)
Gm10081,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr1257,Olfr13,Olfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
974)
GO:0007606)
sensory)perception)of)
chemical)stimulus) 2.39E603)
Gm10081,Gnat3,Grm7,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr1257,Olfr13,Olfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
974,Rtp4,Slc24a4,Tas2r114,Tas2r115,Tas2r122,Trpa1,V1ra8,Vmn1r53)
GO:0004984) olfactory)receptor)activity) 4.83E603)
Gm10081,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr1257,Olfr13,Olfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
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fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
974)
GO:0007608) sensory)perception)of)smell) 5.13E603)
Gm10081,Grm7,Olfr1087,Olfr1089,Olfr109,Olfr1111,Olfr1112,Olfr1257,Olfr13,Olfr13266
ps1,Olfr135,Olfr138,Olfr1431,Olfr146,Olfr1505,Olfr17,Olfr191,Olfr193,Olfr195,Olfr196,Olfr199,Olfr201,Olfr229,Ol
fr292,Olfr356,Olfr357,Olfr366,Olfr368,Olfr38,Olfr389,Olfr435,Olfr453,Olfr48,Olfr714,Olfr715,Olfr724,Olfr725,Olfr
736,Olfr738,Olfr743,Olfr744,Olfr76,Olfr794,Olfr796,Olfr855,Olfr890,Olfr891,Olfr936,Olfr945,Olfr948,Olfr972,Olfr
974,Slc24a4)
GO:0004930)
G6protein)coupled)receptor)
activity) 4.86E602)
Adora2b,Agtr1b,Agtr2,Calcr,Celsr1,Chrm3,Cxcr7,Cysltr1,Ednrb,Emr4,F2rl3,Fzd8,Gm10081,Gm9268,Gpr87,Gpr98,G
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